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Abstract 
This thesis includes two projects: “Novel perfluorinated aromatic amino acids: 
synthesis and applications” and “Thioflavin T dimers as novel amyloid ligands”. 
I) Novel perfluorinated aromatic amino acids: synthesis and applications 
Fluorinated amino acids serve as powerful tools in protein chemistry. Using the 
commercially available Boc-protected pentafluorophenylalanine, we synthesized a 
series of para-substituted tetrafluorophenylalanines via the regioselective SNAr 
reaction. These novel unnatural amino acids display useful and unique properties that 
can be applied to biological systems, including distinct 
19
F NMR signatures, 
pH-dependent amphiphilicity, lipid-binding selectivities, and halogen bonding 
capabilities. 
II) Thioflavin T dimers as novel amyloid ligands 
Fluorescent molecules that specifically target amyloid structures are highly 
desirable for Alzheimer’s disease research. We have designed a dimeric Thioflavin T 
iv 
 
that, through a reduced entropic penalty, has an improved binding affinity 
to Aβ amyloid by up to 70 fold. More importantly, the specificity and the “light-up” 
feature upon amyloid binding have not been sacrificed. Encouraged by the successful 
dimer design, we are further investigating the potential of amyloid-templated 
reactions (photoactive, click chemistry) to tailor-make ligands for amyloids. 
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1.1 Introduction 
 
Fluorine has emerged as a “magic element” in medicinal chemistry and protein 
engineering
[1-4]
. Fluorination is now considered a popular and “standard” strategy for 
modulating the properties of small molecules and peptides. This strategy has been so 
successful that today 20-25% of all pharmaceuticals contain at least one fluorine atom,
[3]
 
despite the fact that organofluorine compounds are virtually absent in nature. The 
applications of fluorination are based on the unique stereoelectronic properties of fluorine. 
The “fluorine effects” in medicinal chemistry and protein engineering are listed and 
briefly introduced below.  
 
I) Fluorination in medicinal chemistry 
1) Metabolic stability enhancement. Fluorine serves as a strong -electron 
withdrawing group and can cause dramatic changes in metabolism. In fact, fluorination is 
primarily used to reduce the oxidation rate of the aromatic rings in drug molecules. In 
addition, fluorination can also 
suppress racemization mechanisms. 
For example, (R)-thalidomide, 
which was used to treat morning 
sickness, epimerizes at 
physiological pH to the (S)-isomer, 
leading to disastrous teratogenic Figure 1-1. Thalidomides and the fluorinated derivatives 
3 
 
side effects. A replacement of the acidic proton with fluorine (Figure 1-1) enables the 
evaluation of each individual isomer
[5]
, and studies have shown the potential utility of 
these isomers in the treatment of leprosy and tumors
[6-7]
. 
2) Minimal steric hindrance. Fluorine is the smallest in size among all elements except 
hydrogen. A C-F bond (1.30-1.43 Å) is only slightly longer than a C-H bond (1.09 Å)
[8]
 
so that fluorination introduces minimal steric perturbation to the parent structure. In the 
antidepressant Fluoxetine (sold as Prozac by 
Eli Lilly, see Figure 1-2), the trifluoromethyl 
group on the para-position of the phenyl ring 
increased the potency for inhibiting 5-
hydroxytryptamine uptake by 6-fold 
compared to the non-fluorinated compound
[9]
, illustrating that fluorination does not 
significantly disturb the steric properties of a molecule.
[10]
. 
3) Altered hydrophobicity. Due to its high electronegativity and small size, fluorine 
has the lowest polarizability among all common elements found in organic compounds
[11]
. 
In addition, a C-F bond can even cause a reduced overall molecular polarizability through 
the carbon framework of the whole molecule. Therefore, fluorination often increases the 
hydrophobicity of the compound
[12]
. It’s important to note that fluorination does not 
always increase the hydrophobicity. Terminal mono-, di-, or trifluorination on an 
aliphatic chain typically decreases the hydrophobicity of the molecule
[13]
, possibly 
because in these cases the increased dipole moment upon fluorination overwhelms the 
decreased polarizability. 
Figure 1-2. Fluoxetine 
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4) Effects on conformational preorganization. Fluorination causes conformational 
changes primarily via stereoelectronic effects. For example, methoxybenzene 
predominately adopts a planar conformation due to the n → Π* donation, while 
trifluoromethoxy-benzene has the –OCF3 group sticking out of the plane (dihedral angle 
for C-C-O-C close to 90
o
, see Figure 1-3a). This conformational difference was  
         
Figure 1-3. a) The conformational preferences for methoxybenzene and trifluoromethoxybenzene; b) 
Cholesteryl ester transfer protein inhibitor. 
successfully exploited to design superior inhibitors of the cholesteryl ester transfer 
protein
[14]
 (Figure 1-3b), which transfers cholesteryl ester from high-density lipoprotein 
to low-density lipoprotein and has been implicated in coronary heart disease. The 
inhibition potency can be increased by 8-fold by modifying the R group from ethyl to 
tetrafluoroethyl (Figure 1-3b), which is rationalized by molecular modeling experiments 
as the out-of-plane orientation of  the R group fits better into the target protein.  
5) pKa perturbation. Due to the high electronegativity, a fluorine substitution can 
dramatically lower the pKa values of adjacent functional groups. For example, 
incorporation of a single fluorine atom onto the imidazole ring lowers the pKa value of a 
histidine residue by several pKa units (pKa, His = 6.0, pKa, (2F)-His = 1.22 and pKa, (4F)-His = 
a)                                                                              b)       
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1.76)
[15]
. Jackson et al. incorporated (4F)-His into ribonuclease A and proved that His12 
and His119 act as general acid/base catalysts, but the proton transfer is not the rate 
limiting step
[16]
. 
6) 
19
F NMR. Organic fluorine compounds do not exist in biology, so that fluorinated 
bio-molecules can be tracked in complex biological systems with zero background. The 
stable and naturally abundant isotope of fluorine, 
19
F, is almost as sensitive (86%) as a 
proton in NMR spectroscopy. 
19
F NMR has therefore evolved to be a sensitive and 
powerful tool in protein analysis, even in living cells
[17]
. One additional advantage of 
19
F 
NMR is the relatively broad range of chemical shift values, which enables the detection 
of minor differences in the environment, for instance, protein folding into membranes
[18]
. 
Grage et al. incorporated 5-F-Trp into the membrane-associated ion-channel peptide 
gramicidin A to investigate the conformation and dynamics of tryptophan residues in 
lipid environments. With 
19
F NMR, their results suggested that the dipole moment plays 
an important role in the ion-channel activity
[19]
. 
7) 
18
F PET imaging. The most important application of fluorination as diagnostic tools 
is the 
18
F positron emission tomography (PET). PET is a nuclear 
medicine imaging technique that produces a three-dimensional image or movie of 
functional processes in the body. The system detects pairs of gamma rays emitted 
indirectly by a positron-emitting radionuclide, which is introduced into the body on a 
biologically active molecule
[20]
. Since the gamma ray pairs are generated strictly 
simultaneously and in opposite directions, PET has extraordinarily high sensitivity and 
resolution, and hence has become one of the best diagnostic tools for tumors. Among the 
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common positron-emitting isotopes in PET, 
18
F has the 
longest half-life time (half-life for 
11
C, 20 min; 
13
N, 10 
min; 
15
O, 2 min; and 
18
F, 110 min). Therefore, 
fludeoxyglucose
[21]
 (Figure 1-4) has become the most 
commonly used radiotracer in PET. More recently, 
Ritter et al. developed methodologies to conveniently and quickly fluorinate aromatic 
rings in pre-drug small molecules with palladium reagents.
[22-23]
 These new synthetic 
methodologies greatly expand the scope of drug molecules for 
18
F PET diagnosis. 
 
II) Fluorination in peptide design and protein engineering  
Beyond small molecule medicinal chemistry, fluorination has also attracted a great 
deal of attention in peptide design and protein engineering. In peptides and proteins, 
multiple incorporations of fluorinated residues are feasible. Therefore, it is possible to 
obtain the emergent fluorine effects, which do not exist in small molecules. 
1) Conformational pre-organization by gauche effects. A good example of fluorine-
induced gauche effects is the investigation of the origins of collagen stability
[24]
. The 
triple helix of collagen is well known to be formed by the repeating trimers containing 
glycine (Gly), proline (Pro) and 4(R)-hydroxyproline (Hyp), which was long believed to 
be due to the additional hydrogen bonding provided by the Hyp residues. Raines et al. 
synthesized collagen-like peptides [Pro-Xaa-Gly]10 with either Hyp or 4(R)-fluoroproline 
(Flp) as Xaa respectively and compared the stability of these two peptides. Surprisingly, 
the Flp peptide is much more stable, with a melting temperature of 91 
o
C (the melting 
Figure 1-4. Fludeoxyglucose 
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temperature for the Hyp peptide is 69 
o
C). NMR and computational studies suggested that 
the gauche effect stabilizes both the exo- conformation of the proline ring and the trans- 
conformation of the backbone amide bond (Figure 1-5), and the resulting predisposition 
of the substituted proline leads to the stabilization of the collegen helix
[25-26]
. 
 
Figure 1-5. The gauche effect of fluorine substitution on proline rings and collagen mimicking 
peptides. a) Section of the structure of a collagen-mimetic peptide with one Pro and one Hyp residue, 
b) The favored conformation of Pro, Hyp and Flp residues, showing the substituted prolines adopt the 
exo- conformation. c) cis–trans Isomerization of the backbone amide bond in Flp residues, in which 
trans- is much more favorable. (This figure has been reproduced from Yoder, N. C.; Kumar, K., Chem. 
Soc. Rev. 2002, 335-341) 
2) “Fluorous effect”. Due to the low polarizability of fluorine atoms, the 
perfluorinated carbons are reluctant to engage in dispersive interactions with either water 
or hydrocarbons and tend to segregate from both aqueous and hydrocarbon-based 
environments. This so-called “fluorous effect” has been utilized to create Teflon-like 
a) c) 
b) 
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proteins. For example, Kumar et al. reported that multi-incorporation of 
hexafluoroleucine into a transmembrane peptide resulted in self-assembly in membranes 
presumably triggered by the “fluorous effect” (Figure 1-6)[27]. 
 
Figure 1-6. Transmembrane helices incorporating multiple hexafluoroleucines self-assemble in 
membranes. Green: fluorine atoms; red: oxygen; blue: nitrogen; purple: peptide backbones. (This 
figure has been reproduced from Bilgicer, B.; Kumar, K.; Proc. Natl. Acad. Sci. USA, 2004, 15324-
15329) 
Generally speaking, the effects of fluorination are based on both covalent and non-
covalent properties of fluorine atoms and contribute widely to protein engineering and 
drug design. In the next section of the introduction, we will focus on the multi-fluorinated 
aromatic amino acids, phenylalanine and tyrosine derivatives, which are also what my 
research has focused on. 
 
III) Fluorinated aromatic amino acids 
Although fluorinated peptides and proteins have attracted much attention, early work 
largely concentrated on the interactions of fluorinated aliphatic amino acids to produce 
“Teflon-like” proteins as introduced previously. However, the “Teflon-like” property 
9 
 
does not apply to fluorinated aromatic amino acids. Instead, the aromatic residues bear 
their own unique properties, interactions and related applications. These novel 
mechanisms include edge-face - interactions, face-face - interactions and CH- 
interactions
[28]
. Here, we briefly introduce the multi-fluorinated phenylalanine and 
tyrosine derivatives and their applications.  
1) Fluorinated phenylalanine (Phe) derivatives. 
The uneven electron distribution of aromatic rings results in the quadrupole moment 
even though the whole molecule does not have a net dipole. In benzene, the sp
2
 carbon is 
more electronegative than hydrogen (electronegativity in Pauling scale: 2.75 v.s. 2.48)
[29]
, 
so the center of the aromatic ring is partial negatively charged while the periphery 
hydrogen atoms are partial positively charged (Figure 1-7a). Therefore, electrostatic 
interactions, such as cation- interactions[30], can be engaged by aromatic  faces. On the 
other hand, the periphery protons can interact with electron rich species to give, for 
example, the edge-face packing of benzene (Figure 1-7b).  
 
Figure 1-7. a) Structure and space filling models (Spartan) showing partial charges and electrostatic 
potentials (red for negative and blue for positive) of non-fluorinated and some multi-fluorinated 
phenyl rings. b) The edge-face interaction between two phenyl rings. 
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However, in multi-fluorinated aromatic rings, the quadrupole moment is reversed due 
to the high electronegativity of fluorine. Therefore, the  face is electron-poor and tends 
to interact with electron-rich species (Figure 1-7a). Also, if there are any remaining 
hydrogen atoms on the multifluorinated arenes, they will be even more electron deficient 
than those on the non-fluorinated ones and more favorable for the edge-face interactions.  
 
Figure 1-8. The face-face interaction between phenyl and pentafluorophenyl rings triggering the 
heterodimer formation of the wild type and fluorinated 2D helices. 
Zheng et. al. strengthened the edge-face interactions and stabilized the villin headpiece 
subdomain (HP35) by mutating the Phe10 residue in the aromatic core with 2,3,4,5-
tetrafluorophenylalanine
[31]
. They also demonstrated the significance of face-face 
electrostatic interactions between phenylalanine and pentafluorophenylalanine  clouds 
with the model peptide 2D, a de novo designed polypeptide that folds into a dimeric 
helix bundle
[32]
. In the folded 2D dimer, the F10 side chains of each monomer stack with 
those of F29 from the other in the face-to-face fashion. A double mutant where both 
phenylalanines are substituted by pentafluorophenylalanine also forms the similar dimer. 
When the two dimers are mixed, they transformed into heterodimers presumably driven 
by the enhanced face-face interaction (Figure 1-8). Also with the 2D system, Pace et. al. 
utilized pentafluorophenylalanine as the control molecule to demonstrate the energetic 
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significance of the CH- interactions between the aliphalic C-H from cyclohexylalanine 
and phenylalanine
 [33]
. 
 
2) Fluorinated tyrosine (Tyr) derivatives. 
Similar to the phenylalanine derivatives, fluorination can decrease the electron density 
on the aromatic ring of the tyrosine side chain, and cause the lone pair of the phenol 
hydroxyl group to be more delocalized to the phenyl ring. This effect directly results in 
the unique properties of multi-fluorinated tyrosines. The first one is the pKa shift on the 
phenol group. The pKa values for the two trifluorinated tyrosine isomers are 6.1 and 
6.6
[34-35]
, and for tetrafluorotyrosine it is 5.6. Compared with the native tyrosine residue 
(pKa = 10), the multi-fluorinated ones are 10
3
-10
4
 folds more acidic and are thus 
deprotonated even at 
physiological pH (7.2 - 7.4). 
Thus, the fluorinated tyrosine 
analogues have been utilized as 
probes to elucidate the 
mechanisms of a number of 
tyrosine-tailoring enzymes, such 
as tyrosinases and kinases
[35-36]
. 
 Another important 
consequence of the tyrosine 
fluorination is an increased redox potential, which ranges from 705 to 968 mV depending 
Figure 1-9. Tyr356 serving as the redox active residue in E. coli 
ribonucleotide reductase. It is proposed to propagate the radical 
between Trp48 and Tyr731. (This figure has been reproduced 
from Seyedsayamdost, M. R.; Yee, C. S.; Stubbe, J., Nat. 
Protoc., 2007, 1225-1235) 
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on the extent and position of fluorination, while the native tyrosine has a peak potential of 
642 mV
[37]
. Stubbe et al. incorporated a variety of di-, tri-, and tetrafluorotyrosines into E. 
coli ribonucleotide reductase. Analysis of the mutants showed that the residue Tyr356 
acts as a redox active residue in this enzyme (Figure 1-9)
[38]
.  
The effects of fluorination on the hydrophobicity of tyrosine are complicated. It is 
suggested that fluorinated tyrosine analogues are more hydrophilic
[1]
, because the phenol 
group is more polarized, more acidic and serves as a better hydrogen bonding donor. 
However, the neutral form of the tetrafluorotyrosine residue is more hydrophobic than 
native tyrosine based on our Spartan calculation results (the logP value for 
tetrafluorotyrosine is 2.76, for tyrosine is 2.13). It may still be true that some of the 
mono- or difluorotyrosines are more hydrophilic, if the fluorine-induced hydrophobicity 
enhancement is not enough to counteract the polarization effect on the phenol –OH group. 
 
 IV) Synthesis of multi-fluorinated aromatic amino acids 
Although fluorination is proven to be a powerful tool in protein analysis and 
engineering, there are only a limited number of fluorinated amino acids available from 
commercial sources, as their synthesis is nontrivial. In the next section we will report a 
facile synthesis of para-X-tetrafluorophenylalanine derivatives via the regioselective SNAr 
chemistry of pentafluorophenylalanine, where X represents a range of functionalities, 
including hydroxyl, alkyl, aryl thiol, amino, and halogens. For convenience of the 
discussion, in later sections we name pentafluorophenylalanine as Z for brevity, and 
para-X-tetrafluorophenylalanine as ZpX with X specifying the para substituent (e.g., 
13 
 
ZpOH stands for tetrafluorotyrosine). By using the starting material with desired 
stereochemistry, the D- or L- isomer of ZpX derivatives can be readily synthesized in 
gram quantities. Consistent with the native analogues in human body, all the amino acids 
described below are in the L-configuration; however, the synthetic protocols should 
enable the synthesis of the D-isomers as well. 
 
1.2 Synthesis of para-X-tetrafluorophenylalanine (ZpX) series 
 
I) The regioselective SNAr reaction on pentafluorophenyl moieties 
Fluorine has the highest electronegativity in the periodic table, so that the C-F -bond 
is highly polarized and the carbon 
atom is partially positively charged. 
Thus, SNAr reactions are favorable 
for highly fluorinated aromatic 
compounds. On the other hand, 
fluorine is in the second row, and 
the p-orbital overlap with carbon is 
perfect in terms of both size and 
geometry. Thus, in fluorinated 
aromatic compounds, the dipole 
moment from the C-F -bond can 
force fluorine to partially donate its 
Table 1-1. Activation effects of fluorine substitution on 
different positions in the SNAr reaction: ratios of measured 
rate constants (MeO
-
/MeOH, 58 
o
C)
[40]
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lone pair to the aromatic ring.  
By combining the effects of fluorine as a -electronegative but -electropositive group, 
we can conclude that as an electron withdrawing group, m-F > o-F > p-F. Firstly, m-F 
does not have the electron donating resonance effect and serves as the strongest one, 
while between o-F and p-F, o-F has stronger electron withdrawing inductive effect due to 
the shorter distance. Therefore, for 2, 3, 4, 5, 6-pentafluorophenyl moieties, the SNAr 
reaction will regioselectively occur at the 4-position, because the 4-position has two m-F 
and two o-F substitutions and all the other positions have one electron donating p-F 
substitution
[39]
. 
Additionally, the empirical data of the activation effects of different positions of 
fluorine substitution in the SNAr reaction are shown in Table 1-1
[40]
. Thus, by calculating 
the acceleration ratios for a pentafluorophenyl moiety (like the side chain of Z), we can 
see the regioselectivity is more than two orders of magnitude, with the para-fluorine 
substituted exclusively (Figure 1-10a).  
Based on this fact, we hypothesized that we can directly synthesize a series of ZpX 
amino acids from Boc-Z-OH (abbreviation for -amino Boc-protected, -COOH free, 
same below). The nucleophiles can be hydride, oxygen nucleophiles, nitrogen 
nucleophiles and sulfur nucleophiles
[40]
. Furthermore, from the readily accessible 4-
substituted products, we can continue modifying the group and expand the scope of this 
class of unnatural amino acids (Figure 1-10b). 
15 
 
 
Figure 1-10. Expanding the repertoire of fluorinated aromatic amino acids via SNAr chemistry. a) 
Regioselectivity of the SNAr reaction on perfluorophenylalanine. b) Scope of the SNAr reaction of Boc-
Z to obtain ZpX derivatives with diverse functionality.   
 
II) The “O” nucleophile and the subsequent cross-coupling reactions 
ZpOH (tetrafluorotyrosine) serves as a powerful probe to elucidate the mechanisms of 
a number of tyrosine-tailoring enzymes as we previously introduced. Therefore, it came  
  
Scheme 1-1. Previously reported synthetic routes for ZpOH. 
a) b) 
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as a surprise to us that there was no reported chemical synthesis of ZpOH that is stereo-
specific. The only chemical synthesis of ZpOH was reported by Kang et. al. that couples 
4-methoxy-tetrafluorobenzyl bromide to diethylacetamidomalonate to give the racemic 
mixture of O-methyl protected ZpOH (Scheme 1-1a)
[41]
.  
A biosynthetic route for preparing fluorotyrosine analogues in the enantiomerically 
pure form has been developed by Cole et al. and Stubbe et al.
[35, 37]
 This approach 
capitalizes on the enzymatic activity of tyrosine phenol lyase that converts fluorinated 
phenols to the corresponding L-fluorotyrosines in presence of pyruvate and ammonia 
(Scheme 1-1b). While this strategy works well with phenol (< 1 d, > 90% yield), the  
 
Scheme 1-2. The enzymatic mechanism of tyrosine phenol lyase. 
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tetrafluorinated analogue appears to be a poor substrate for the enzyme. Consequently, 
the preparation of ZpOH takes 3-4 weeks and requires high concentrations of the enzyme. 
This phenomenon is explained by the enzymatic mechanism, in which a key step is the 
Michael addition between the aminoacrylate intermediate and phenolate (Scheme 1-2)
[42]
. 
This step is unfavorable both thermodynamically and kinetically when the phenol 
substrate is electron deficient. The experimental data also showed that catalysis efficiency 
drops with increasing number of fluorine substituents. 
As we described previously, we chose Boc-Z-OH as the starting material to synthesize 
ZpOH via the SNAr reaction. Our first attempt directly using hydroxide as the nucleophile 
failed to give any product in 
organic or aqueous media 
(Table 1-2). One possible 
reason is that the hydroxide 
anion serves as both a 
hydrogen bonding donor and 
accepter, and is solvated tightly through hydrogen bonding and strong dipole-dipole 
interactions in either water or polar organic solvents (it is insoluble in non-polar solvents). 
The thick layer of solvent molecules surrounding hydroxide reduces the reactivity. Hence 
we changed the nucleophile to methoxide, which only acts as a hydrogen bonding 
acceptor and so will not be solvated as strongly. The reaction proceeded nicely to 
completion with methoxide as we expected. Sodium as the counter-ion afforded a slightly 
Table 1-2. Summary of the SNAr conditions to make ZpOH 
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faster reaction than potassium presumably because sodium is a stronger Lewis acid 
(Table 1-2).  
However, difficulty was encountered with the removal of the O-methyl protecting 
group: BBr3 resulted in a complex mixture; even the milder alternative NaSC2H5
[43]
 
caused the cleavage of the Boc- protecting group, which made the purification difficult. 
Finally, we used sodium allyloxide, which reacted as readily with Boc-Z-OH (Table1-2) 
to give the O-allyl protection on the side chain. The advantage of the O-allyl protection is 
that the allyl ether can be cleaved specifically under mild conditions with a Pd catalyst
[44]
.  
Our final synthetic route for Fmoc-ZpOH-OH is shown in Scheme 1-3. Sodium 
allyloxide was prepared in situ by dissolving sodium metal in allyl alcohol, and the SNAr 
reaction was complete within 6 h at 90 
o
C to yield Boc-ZpOAllyl-OH (compound 1-2). 
The protecting group on the -amino position was converted from Boc- to Fmoc- in one 
pot, and the allyl ether was then cleaved by using Pd(PPh3)4 in presence  of PhSiH3
[44]
 to 
yield the final product Fmoc-ZpOH-OH (compound 1-4). Although the allyl deprotection 
step generates some greasy byproducts that are hard to separate on a silica gel column, 
they can be easily removed by ether extractions at pH 12 (Fmoc-ZpOH-OH will be 
double negatively charged and stay in the aqueous phase). We confirmed the absence of 
epimerization by conjugating Fmoc-ZpOH-OH to a chiral amine, the product of which 
elutes as a single peak during HPLC analysis. The lack of epimerization under such basic 
conditions is presumably because the negatively charged carboxylate prohibits the 
deprotonation on the -carbon. The synthetic route has an overall yield of 72% and can 
easily afford gram quantities of Fmoc-ZpOH-OH for peptide synthesis (ZpOH does not 
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require side chain protection in regular Fmoc solid phase peptide synthesis (SPPS)
[45]
). If 
the side chain protection is necessary, the intermediate Fmoc-ZpOAllyl-OH (compound 
1-3) is compatible and the allyl deprotection can be conveniently carried out either in 
solution or on resin after the peptide synthesis. 
 
Scheme 1-3. Synthesis of ZpOH. 
By slightly modifying the synthetic route, we can obtain Boc-ZpOTf-OMe (compound 
1-7, Scheme 1-4), which can serve as a starting material for cross-coupling reactions in 
order to extend the carbon-carbon chain on the perfluorophenyl side chain. In this way 
we can generate different types of perfluoroaryl-aryl, aryl-vinyl and aryl-alkyl 
compounds, and utilize them to increase the hydrophobicity and investigate the 
strengthened - interactions in peptides.  
The synthesis of Boc-ZpOTf-OMe begins with the protection of the -carboxyl of 
Boc-ZpOAllyl-OH (compound 1-2) using iodomethane. After methylation and the 
cleavage of the allyl ether, Boc-ZpOH-OMe (compound 1-5) was treated with Tf2O to 
produce Boc-ZpOTf-COOMe with an overall yield of 55% over 4 steps.  
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Scheme 1-4. Synthesis of ZpOTf and the related Suzuki coupling reactions 
The first cross-coupling reaction we attempted was the Suzuki coupling between Boc-
ZpOTf-COOMe and 3, 5-dimethylphenylboronic acid
[46-47]
 (Scheme 1-4). The reaction 
proceeded smoothly with 95% yield. The resulting ZpAr product 1-8b was then 
converted to Fmoc-protected amino acid sequentially by the hydrolysis of the methyl 
ester with LiOH, deprotection of Boc with TFA and Fmoc protection on the -amino 
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group in one pot. The overall yield for the final product 1-9b was 81 % from Boc-ZpOTf-
COOMe. Marfey’s test proved that no epimerization happened[48].   
 
Scheme 1-5. The Sonogashira reaction with ZpOTf 
The Suzuki coupling was not as perfect when we started with vinylboronic acid 
dibutyl ester, in which only 75% of ZpOTf was converted to ZpVinyl product 1-8a, while 
the other 25% went back to ZpOH (1-5). The same problem became even more serious 
for Sonogashira coupling
[49]
 (Scheme 1-5), in which the ratio of the desired product 1-8c 
versus ZpOH was only 1/3. However, upon an addition of 2 equiv. of LiBr, the yield of 
1-8c can be increased to 70%. One more interesting phenomenon happens in the Boc- 
deprotection for 1-8a, in which the vinyl group was 100% reduced by the carbocation 
scavenger triisopropylsilane, and the final product turned out to be Fmoc-ZpEt-OH (1-9a, 
Scheme 1-4). Alternative methods are then necessary to incorporate ZpVinyl into 
peptides. 
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Scheme 1-6. A possible mechanism for the generation of ZpOH in Sonogashira reaction 
The reason why ZpOH was generated is hypothesized with the Sonogashira reaction 
mechanism as an example (Scheme 1-6). Firstly the initial oxidative addition yields the 
Ar-Pd-OTf intermediate (M1), which is supposed to undergo transmetalation with 
alkynyl cuprous (yielding M2), trans-cis isomerization and irreversible reductive 
elimination to yield the coupling product 1-8c. However, if the transmetalation is not fast 
enough, a ligand exchange may take place between M1 and the trace amount of water in 
the system in presence of base. This side reaction generates Ar-Pd-OH (M2’), which can 
also potentially undergo reductive elimination and generate ZpOH (1-6). Although this 
reductive elimination does not seem favorable on the electron deficient ring, it is 
irreversible and may not be the rate determining step. The generation of M2’ competes 
with that of M2, which explains all the previous results. In Suzuki coupling, the boronic 
acid is very reactive and ZpOH was not observed, while the boronic ester is not as 
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reactive so that the generation of ZpOH became possible. In the Sonogashira reaction, the 
reactivity of the cuprous reagent is even poorer, so the byproduct was obtained in as 
much as 75% yield. 
The addition of LiBr potentially leads to another transmetalation with M1, which 
should be favorable due to the hard-soft Lewis acid and base theory (HSAB). The hard 
pair Li
+
 and TfO
-
 associates and the soft pair Pd(II) and Br
-
 forms the intermediate Ar-
Pd-Br (M3). Also based on HSAB, M3 is favorable to transmetalate with alkynyl 
cuprous and yield M2 due to the formation of the stable CuBr, which can also be 
additionally guided by the presence of Li
+
. The summary of these two transmetalations is 
the acceleration of the M1 to M2 conversion. Since the generations of M2 and M2’ are 
competing processes, the side reaction is suppressed simultaneously.  
Furthermore, we tried Miyaura borylation
[50]
 with ZpOTf in order to obtain boronic 
acid-based amino acids (Scheme 1-7, the related application will be introduced in section 
1.3). One modification on the ZpOTf analogue is that t-butyl was used as the -carboxyl 
protecting group instead of methyl, because the pinacol ester in the potential product 
ZpBpin (compound 1-13) is sensitive to aqueous acid or base, which is essential for the 
methyl ester cleavage. t-Butyl ester, which can potentially be cleaved together with Boc- 
under water-free conditions (details will be introduced in section 1.5), is obviously a 
better choice. The t-butyl ester was formed with t-butyl trichloroacetimidate
[51]
, and Boc- 
ZpOTf-OtBu was synthesized efficiently. Unfortunately, Miyaura borylation failed to 
yield any desired product under various conditions (Scheme 1-7), and LiBr is not helpful 
here. This failure is not too surprising given our previous hypothesis on the mechanism.  
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Scheme 1-7. Miyaura borylation with ZpOTf 
Since the transmetalation acceleration based on the cuprous-bromide soft-soft match in 
Sonogashira coupling does not apply in the Miyaura reaction, in which B2pin2 or HBpin 
takes the place of the cuprous reagent, and both of them are hard Lewis acids. An 
alternative synthesis for Fmoc-ZpBpin-OH (compound 1-14) is proposed using Boc-
ZpH-COOH (compound 1-15) directly (Scheme 1-7)
[52]
. 
 
III) The “S” nucleophile 
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Similar to the ZpOH synthesis, the use of a sulfur nucleophile (e.g., thiolate) in the 
SNAr reaction afforded the para-mercapto analogue ZpSH. Initially, we treated Boc-Z-OH 
with NaSH, which turned out to be too reactive and predominantly gave a thioether with 
two Z molecules crosslinked as a result of sequential SNAr reactions within 1 h.  
 
Scheme 1-8. Synthesis of ZpSH series 
To prevent dimerization, we chose 4-methoxy benzenemethanethiol (PMBSH, 
Scheme 1-8) as an alternative nucleophile, which reacted readily with Boc-Z-OH in the 
presence of NaOH in iPrOH/H2O co-solvents to give Boc-ZpSPMB-OH  (compound 1-
16) in 88% yield. Similar protecting group conversion yielded the product Fmoc-
ZpSPMB-OH (compound 1-17), which is compatible with SPPS via Fmoc/tBu chemistry. 
No epimerization was observed by Marfey’s test. The PMB protecting group was 
efficiently removed to give Fmoc-ZpSH-OH (compound 1-18) by using Hg(OAc)2 under 
mild conditions
[53]
. A similar protocol was also previously used for removing the PMB 
group from peptides in solution
[54]
. The side chain thiol of Fmoc-ZpSH-OH was then re-
protected with trityl chloride, since trityl thioether can be directly deprotected along with 
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other regular protecting groups in Fmoc chemistry by TFA treatment. The overall yield 
for Fmoc-ZpSTrt-OH (compound 1-19) is 51% over 4 steps. 
 
IV) The “N” nucleophile and the Sandmeyer reactions 
The SNAr chemistry of Boc-Z-OH also applies to nitrogen nucleophiles. Ghadiri et. al. 
previously reported the synthesis of 
racemic ZpN3 through the SNAr chemistry 
(Scheme 1-9)
[55]
. In their work, the L-
isomer of ZpN3 was obtained through 
kinetic resolution with Aspergillus 
melleus acylase-I and incorporated into 
peptides as a photoactive group.  
We carried out a similar synthesis 
using the pure L-enantiomer of Boc-Z-OH (Scheme 1-10). The t-butyl protected substrate 
was treated with Bu4NN3/NaN3 in DMF, and Boc-ZpN3-OtBu (compound 1-21) was 
obtained in 81% yield. No epimerization was observed based on Marfey’s test[48]. The 
cleavage of Boc- and t-butyl ester was finished together with TFA, and the -amino was 
re-protected with Fmoc-OSu in one pot. The product Fmoc-ZpN3-OH (compound 1-22) 
is compatible with regular Fmoc SPPS chemistry. The three-step synthesis gave Fmoc-
ZpN3-OH (compound 1-22) with an overall yield of 65%. Reduction of Fmoc-ZpN3-OH 
was best accomplished by using propylene dithiol under mild conditions to afford Fmoc-
ZpNH2-OH (compound 1-23) in excellent yield
[56]
. The reaction only took 5 min to 
Scheme 1-9. Synthesis of ZpN3 by Ghadiri et. al.
[55]
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achieve completion due to the electron deficiency of the substrate. Propylene dithiol 
treatment effectively converted ZpN3 in a peptide into ZpNH2 as well; in other words, 
ZpN3 conveniently serves as a precursor for the synthesis of peptides containing ZpNH2, 
the azido group can be considered as a “protected” amino group.  
 
Scheme 1-10. Synthesis of ZpNH2 
We then hypothesized that ZpNH2 could be converted into a variety of fluorinated 
phenylalanine analogues through diazonium chemistry
[57]
. The Sandmeyer reaction is 
widely used to access halogenated aromatics
[58]
, and from this reaction we have 
developed synthetic protocols for the para-halogenated (Cl, Br, I) tetrafluoro-
phenylalanines (ZpCl, ZpBr and ZpI). Unfortunately, since the heavily fluorinated 
anilines (ZpNH2) are less nucleophilic and more difficult to generate the diazonium 
species, the Sandmeyer chemistry is less straightforward. After a few initial failures, we 
decided to use the model compound 1-28 (para-carboxyl-tetrafluoroaniline, Table 1-3) to 
investigate the diazonium halogenation conditions. Indeed, treating 1-28 with the 
canonical condition of diazonium-iodination (TsOHH2O/NaNO2/KI) only afforded less 
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than 60% conversation of the starting material, indicating inefficient formation of the 
diazonium species. In addition to the desired product 1-29, the reaction yielded a major  
 
 
Table 1-3. Optimization of diazonium iodination conditions with the model compound.
 
a
optimized condition: 0.05 M in CH3CN, 2 eq. I2 and 1.5 eq. 
t
BuONO. 
b
neither 1-29 nor 
1-30 was generated 
byproduct, the para-hydrogenated compound 1-30.  This byproduct is generated 
presumably because the diazonium intermediate and the subsequent phenyl radical are 
highly reactive and extract a hydrogen atom from the solvent molecules. This hypothesis 
is supported by the solvent dependence of byproduct formation: THF gives exclusively 
the hydrogenated byproduct, while CH3CN favors the desired iodo product (Table 1-3) 
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and affords a mixture and 1-29 and 1-30 in a ratio of 3:1. Interestingly compound 1-31 
(with a para-benzyl substituent) is obtained as the sole product when toluene is used as a 
co-solvent. This is consistent with the radical mechanism of the diazonium chemistry, 
which leads to cross coupling between the fluorinated phenyl radical and toluene. This 
observation also led us to suspect that the benzylic position of TsOH might participate in 
the radical chemistry and therefore should be avoided in the diazonium chemistry. The 
alternative condition
[59]
 (tBuONO/I2) reduced the byproduct formation to ~ 5%. 
Fortuitously, this condition also improved the diazonium formation to give complete 
conversion of the starting material. 
The optimized condition for the model reaction was then implemented for the 
synthesis of the halogenated tetrafluorophenylanines. We initially subjected Fmoc-
ZpNH2-OH to the iodination condition, which generated a messy mixture. NMR analysis 
suggested possible degradation of the Fmoc group, presumably because the benzylic 
substructure of Fmoc was attacked by the radical species as we discussed previously. 
Alternatively, we used the trifluoroacetyl to protect the -amino group (CF3CO-ZpNH2-
OH, compound 1-25, Scheme 1-11) in the diazonium chemistry, which does not bring 
additional hydrogen atoms to the substrate and is unfavorable to form radicals. The 
iodination with CF3CO-ZpNH2-OH afforded ZpI in excellent yield (89%). Similar to the 
model reaction, the byproduct ZpH was found to be ~5%. Use of CuX2/CuX (X = Br or 
Cl) in the diazonium chemistry gave ZpBr and ZpCl respectively in good yields. In 
comparison to iodination, the byproduct (ZpH) percentage was found to be similar for 
bromination and slightly higher for chlorination (~12%), consistent with the relatively 
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low reactivity of chlorine in radical chemistry. The protecting group conversion was 
accomplished through a one-pot process to give Fmoc-ZpX-OH (X = Cl, Br, I, 
compounds 1-27a-c), the form ready for peptide synthesis. The enantiopurity of these 
amino acids was confirmed by the Marfey’s test. HPLC purification for 1-27a-c can 
efficiently remove ZpH byproduct if high purity is needed. 
 
Scheme 1-11. Synthesis of ZpCl, ZpBr and ZpI 
Here we want to highlight the advantage of our synthetic route for ZpXs by 
introducing another failed ZpI synthetic route (Scheme 1-12) we had attempted 
previously. Generally speaking, to synthesize an unnatural amino acid, one can either 
build up the backbone first and then modify the side chain functional groups, as we did in 
our ZpX series, or prepare the “side chain” first then couple it onto an amino acid 
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backbone precursor (usually also a chiral auxiliary). As shown in Scheme 1-12, we 
synthesized a series of para-iodotetrafluorobenzyl derivatives (compounds 1-36a-c) with 
different leaving groups, and tried to couple them onto Schöllkopf’s chiral auxiliary[60] 
(compound 1-38, obtained from the double O-ethylation of 1-37 with triethyloxonium 
tetrafluoroborate
[61]
). The synthesis started from the Suzuki coupling between 1,4-
diiodotetrafluorobenzene and vinylboronic acid dibutyl ester. After ozonolysis, the mono-
alkylated product 1-34 was isolated by silica gel chromatography as an aldehyde. 1-34 
was reduced via Meerwein-Ponndorf-Verley reduction
[62]
, and the obtained alcohol 1-35 
was then converted to 1-36a-c with bromide, diphenyl phosphate or tosylate as the 
leaving group. Unfortunately, under the few attempted conditions, the coupling between 
any one of 1-36a-c with 1-38 failed to yield the desired product, 1-39, which can be 
converted to Fmoc-ZpI-OH (compound 1-27c), while the major product turned out to be 
the dimerized chiral auxiliary (compound 1-40).  
One plausible mechanism for the generation of 1-40 is proposed (Scheme 1-13). The 
deprotonated 1-38 with Li
+
 as the counter-ion (compound 1-41) can potentially undergo 
halogen-lithium exchange with any of 1-36a-c to generate iodinated chiral 
auxiliary(compound 1-42), which readily reacts with another molecule of 1-41 to yield 
the dimer 1-40. The failure of these attempts indicates the reactivity of the ZpI side chain 
and the necessity to leave the iodination for a relatively later stage of the synthesis. 
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Scheme 1-12. A failed strategy to synthesize ZpI 
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Scheme 1-13. A plausible mechanism for the chiral auxiliary dimerization  
 
1.3 Applications of ZpX series in biological systems 
 
I) 2D 
19
F NMR analysis of peptides 
The application of 
19
F NMR in protein analysis was previously discussed in section 
1.1. In order to utilize our novel amino acids as protein probes, we characterized their 
signatures in 
19
F NMR. Despite their structural similarity, the tetrafluorinated 
phenylalanine analogues display a wide distribution of their 
19
F resonances, ranging from 
-120 to -165 ppm (Table 1-4). The -electron donating substituents (-F, -OH, -NH2) on 
the para- position (para- towards the -carbon of the amino acid backbone, same below) 
elicit significant upfield shift of the meta- fluorine resonances (Table 1-4, in Italic), 
which appear around -163 ppm. On the contrary, the bromo and iodo substituents on the 
para- position cause downfield shift of the meta- fluorines, with ZpBr and ZpI displaying 
a resonance around -133 and -120 ppm respectively. 
 
34 
 
 CDCl3 CD3OD 
Z -161.5 -154.4 -142.0 -165.0 -159.0 143.6 
ZpH -138.7 -142.6 -141.2 -144.4 
ZpCl -140.7 -141.3 -142.7 -143.7 
ZpBr -133.0 -140.8 -135.9 -142.3 
ZpI -120.1 -140.2 -123.1 -142.2 
ZpN3 -151.3 -142.5 -154.3 -144.6 
ZpNH2 -161.5 -145.3 -164.0 -148.0 
ZpOH -163.4 -144.8 -164.9 -147.4 
ZpO
-
 - - -168.2 -152.1 
ZpSH -137.3 -142.2 -139.8 -144.4 
ZpS
-
 - - -138.4 -148.7 
 
Table 1-4. 
19
F NMR chemical shifts (ppm) of ZpX series in CDCl3 and CD3OD, with the data for 
meta- fluorines in Italic (reference: fluorobenzene, -113.15 ppm). 
 
We further examined the environment sensitivity of 
19
F chemical shifts by using 
chloroform and methanol as solvents respectively (Table 1-4). Consistent with previous 
reports,
 
the 
19
F resonances are highly sensitive to the local environment: a polar solvent 
like methanol gives resonances that are upfield shifted by as much as 3 ppm in 
comparison to chloroform. On the other hand, the ionizable residues (ZpOH and ZpSH) 
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show dramatic chemical shift changes in response to the environment pH, as a result of 
protonation or deprotonation of their side chains.
 
 
Figure 1-11. 
19
F_
19
F COSY spectrum of a magainin 2 mutant incorporating three ZpX (ZpBr, ZpCl, 
ZpN3) residues. The highly dispersed 
19
F resonances enabled facile assignment of all peaks in 
19
F 
NMR. 
 
These characteristic chemical shifts should allow facile assignment of 
19
F resonances 
for peptides that incorporate multiple fluorinated residues. As a proof-of-concept 
experiment, we have incorporated three ZpX residues (ZpCl, ZpBr, and ZpN3) into 
magainin 2 (mag2), a well known membrane-lytic peptide
[63]
.
 
Due to their distinct 
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chemical shifts, the meta-fluorine resonances of ZpBr and ZpN3 were readily identified, 
which in conjugation with the 
19
F-
19
F COSY
[64]
 data enabled unambiguous assignment of 
all 
19
F peaks (Figure 1-11). 
 
II) Halogen bonding in peptides  
Halogens (Cl, Br and I) are known to feature anisotropic electron density around the 
atoms in organic halides, and a region of positive electrostatic potential is present along 
the covalent bond (Figure 1-12). Thus, the electrophilic pole on the halogen atom, which 
is known as the “-hole”, can accept n or  electrons of nucleophiles and hence form the 
halogen bonding (XB) interactions 
[65-66]
. Main properties of halogen-bonding are listed 
below: 
1) The strength of XB donor 
increases in the order of Cl < 
Br < I, C(sp
3
)-X < C(sp
2
)-X < 
C(sp)-X. 
2) Neighboring electron 
withdrawing groups to the 
donor halogen enhance the XB 
strength. 
3) The strength of XBs is 
comparable with that of 
Figure 1-12. The molecular electrostatic potential: CF4 (topleft), 
CF3Cl (topright), CF3Br (bottomleft) and CF3I (bottomright) 
(This figure has been reproduced from Metrangolo, P.; Meyer, 
F.; Pilati, T.; Resnati, G.; Terraneo, G., Angew. Chem. Int. Ed., 
2008, 6114-6127) 
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hydrogen bonds (HBs), in the range of 10-200 kJ/mol. 
4) XBs are much more sensitive to steric hindrance, which is probably the biggest 
difference from HBs. 
With these properties, XB has 
been utilized in liquid crystals, 
magnetic and conducting materials. 
As a unique mechanism of 
interaction, it is also attractive in the 
studies of biological systems. In 
2011, Diederich et al. reported a 
systematic study of XB interactions 
in human proteinase Cathepsin L 
(hCatL) (Figure 1-13)
[67]
, in which 
the XB between Gly61 carbonyl and 
Cl, Br or I enhanced the protein-
ligand binding affinity in the order of 
Cl < Br < I.  
Our interest is to probe the effects of XB(s) on the secondary structure of biological 
molecules, and also the similarity and difference between XB(s) and other non-covalent 
interactions. Since haloarenes are usually good XB donors and adjacent electron-
withdrawing groups can enhance XB
[65]
, ZpI is obviously excellent as a candidate to 
incorporate XB into peptides. The first model system we chose is the PinWW domain 
Figure 1-13. Halogen bonding interaction with amide 
carbonyl in the binding pockets of hCatL. (This figure 
has been reproduced from Hardegger, L. A.; Kuhn, B.; 
Spinnler, B.; Anselm, L.; Ecabert, R.; Stihle, M.; Gsell, 
B.; Thoma, R.; Diez, J.; Benz, J.; Plancher, J.; 
Hartmann, G.; Banner, D. W.;  Haap, W.; Diederich, F., 
Angew. Chem. Int. Ed., 2011, 314-318) 
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(Figure 1-14), a 34-residue β-sheet peptide[68], with which we were able directly compare 
the energetics of XB and HB in a solvent-exposed loop of a biologically relevant system. 
Collaborating with C. J. Pace, we made a series of mutants of PinWW and compared 
their stability (Table 1-5). The control mutant is F25 N30E, in which Asn was substituted  
 
 
Figure 1-14. Cartoon showing the 3D structures of two PinWW domain mutations, left: F25 N30E; 
right: F25YN30E. 
 
PinWW mutant Tm (ºC)
a
 ∆Gf (
kcal
/mol)
b
 ∆∆Gf (
kcal
/mol)
c
 
F25 N30E 46.09 ± 0.14 -2.16 ± 0.04 -- 
F25Y N30E 52.32 ± 0.12 -2.91 ± 0.06 -0.75 
F25Z N30E 52.82 ± 0.21 -3.25 ± 0.08 -1.09 
F25ZpI N30E 52.23 ± 0.12 -3.23 ± 0.05 -1.07 
a
Calculated by fitting thermal denaturation curves  
b
Calculated by fitting chemical denaturation curves  
c∆∆Gf  = ∆Gf mutant - ∆Gf F25 N30E 
Table 1-5. PinWW mutants and the comparison of the stabilities. 
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by Glu to set a net negative charge to enhance the electron richness and flexibility on the 
HB/XB acceptor residue. By comparing F25Y N30E to F25 N30E, we can see the 
additional hydrogen bonding between Tyr and Glu can enhance the stability by 0.75 
kcal/mol. However, a similar comparison between F25Z N30E and F25ZpI N30E did not 
show any significant difference. 
The failure of PinWW domain studies indicate that it is essential to systematically 
learn the unique characters of XB before incorporating XB into biological systems. There 
are a few unknown questions to answer:  
1) What is the best XB acceptor that in peptides?  
2) How strong can XB potentially be?  
3) Can π clouds serve as XB acceptors[69] as well as lone pairs?  
4) Can XB be significant in both hydrophobic and aqueous environments?  
5) How much stronger is XB than the interaction between an electron-poor C-H and 
electron donors (this is argued as C-H hydrogen bonding or dipole-dipole interaction)? 
In order to find out the answers, 
19
F NMR titration experiments were carried out to 
expose the nature of the interactions and obtain the association constants by calculating 
the chemical shifts upon interacting with electron donors. To simplify the system, we 
used para-iodotetrafluorobenzoic acid methyl ester in cyclohexane solvent to mimic ZpI 
residue in membrane environments, while para-iodotetrafluorobenzoic acid in water as 
ZpI residue exposed in aqueous environments (Figure 1-15). For convenience and 
consistency, we still call these small molecules “ZpI”. Similarly, some other small 
molecules are utilized as pseudo-“Z” and “ZpH” as controls (Figure 1-15).  
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In terms of the XB acceptors, the nitrogen lone pair is considered the best
[70]
, which 
can be explained by HSAB theory. Since aliphatic amines are protonated at physiological 
pH, aromatic nitrogens with lower pKa values (pyridine and imidazole) were chosen in 
our experiments to stand for the relative amino acid residues (some are unnatural) in 
biological systems. We also tested electron-rich  systems (indole and pyrrole) to figure 
out if  clouds are also capable XB acceptors (Figure 1-15).  
 
Figure 1-15. Small molecules as amino acid mimics in the 
19
F NMR titration experiments 
41 
 
As we discussed previously, the chemical shifts of meta-fluorine (Figure 1-15, labeled 
on ZpI) reflect the environment changes most significantly. Hence we plotted the 
chemical shift changes of meta-fluorine (Figure 1-16, as m-m0) against the concentration 
of the XB acceptor and calculated the association energy based on the fitted hyperbolic 
curves (when the m-m0 value is half its maximum,  Ka = 1/[acceptor]). 
 
 
Figure 1-16. Titration curves of small molecule halogen bondings. 
The results showed that in cyclohexane, XB interaction between ZpI and Py is 
significant, with Kd = 0.35 M
-1
, ∆G = -1 kcal/mol. The meta-fluorine signal is shifted by 
close to 1 ppm. Under the same conditions, Z or ZpH do not interact with Py, which 
further indicated the interaction is specific. In contrast, Z/ZpH/ZpI are not significantly 
Z/ZpH/ZpI-Py in cyclohexane                                        Z/ZpH/ZpI-Pyr in cyclohexane 
Z/ZpH/ZpI-Indole in cyclohexane                                               Z/ZpI-Im in water   
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different in terms of interacting with  systems (indole or Pyr). Due to the complexity of 
multiple possible weak interactions (- face-face, edge-face, etc.), it’s hard to interpret 
the halogen- interactions. On the other hand, neither Z nor ZpI showed any interactions 
with Im in water, even though Im bears more electronegative nitrogen lone pairs than Py. 
This fact indicates that in water (generally, protic solvents) the XB interaction is 
completely overwhelmed by strong hydrogen bonding with solvent molecules, which 
perfectly explains the failure of our PinWW system.   
From our 
19
F NMR titration experiments, it is concluded that, in order to utilize XB in 
a biological system, we have to place it in hydrophobic environments (Diederich’s XB is 
in water-free binding pockets
[67]
). Additionally, the aromatic nitrogen lone pair is the best 
candidate as the acceptor
[65]
. The high steric flexibility requirement should also be taken 
into account
[65]
.  
 
Figure 1-17. ErbB2 as the model system for halogen bonding 
Combining all these considerations, we propose that XB may enable the control of 
protein-association in lipid membranes. Towards this end, we will use ErbB2 as the 
model system (Figure 1-17). ErbB2 is a transmembrane helix which dimerizes in 
membranes
[71]
. The ErbB2 system can potentially provide the essential hydrophobic 
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environment and also the geometry of XB interactions. Work along this direction is 
currently underway. 
 
III) pH dependent membrane lytic peptides (in collaboration  with F. Wang)  
Membrane-lytic peptides have attracted a great deal of attention in the search for novel 
antibiotics that are less prone to drug resistance
[72-75]
. For the same reason, membrane-
lytic peptides also serve as potential anti-tumor drug candidates. However, the toxicity of 
these peptides to healthy mammalian cells limits their application as drug molecules. The 
design of pH-sensitive membrane-active peptides, which suppresses the membrane-lytic 
activity at physiological pH and increases the selectivity, has been largely relying on the 
protonation of Glu or Asp side chains, which display pKa values of 4.3 and 3.9 
respectively. Residues with higher pKa values are desirable considering the pH values of 
(patho)physiological relevance are generally above 5.5
[76]
. Considering the pKa value of  
pH=5 pH=7
Bound
Membrane Lysis
Unbound
Membrane Intact
F
F
OHF
F
F
F
OHF
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Figure 1-17. ZpOH mutated magainin 2 serves pH dependent membrane-lytic peptide. 
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ZpOH is 5.6, it is a good candidate to provide novel pH sensing elements in the design of 
membrane-lytic peptides. 
Again we used the well characterized membrane-lytic peptide magainin 2 (mag2) as 
the model system to test the potential of ZpOH in pH sensing (Figure 1-18)
[63]
. Mag2 is a 
twenty-three-residue peptide that folds into an amphiphilic helix upon membrane binding. 
Three mag2 variants were synthesized on the Rink-MBHA amide resin using the standard 
Fmoc/HBTU chemistry. A dansyl group was installed at the N-termini of all peptides to 
facilitate binding affinity measurement and concentration calibration. As shown in Table 
1-6, peptide 2 is the corresponding Tyr control for the designed pH-responsive peptide 1. 
For comparison, we also synthesized peptide 3 incorporating three Glu residues, which 
have been widely used as pH sensing elements in previous reports. 
 
WT Mag2 GIGKFLHSAKKFGKAFVGEIMNS 
1 dansyl-GIGK(ZpOH)LHSAKK(ZpOH)GKA(ZpOH)VGEIMNS 
2 dansyl-GIGKYLHSAKKYGKAYVGEIMNS 
3 dansyl-GIGKELHSAKKEGKAEVGEIMNS 
 
Table 1-6. The Sequences of mag2 mutants, residues of interest are shown in bold: ZpOH 
(negative at pH7.0, neutral at pH5.0); Y (neutral in both); E ( negative in both) 
The membrane-lytic activity of the mag2 mutants were tested using a calcein leakage 
assay
[77]
 (Figure 1-18). At neutral pH (7.0), no membrane lysis was observed upon 
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mixing the peptides 1 or 3 with liposomes. The tyrosine variant 2 afforded ~18% of 
membrane damage. Acidification to pH 5.0 upon HCl addition caused little change for 
the control peptides 2 and 3. In sharp contrast, the ZpOH mutant 1 displayed a dramatic 
increase in calcein fluorescence, showing that the ZpOH side chains indeed serve as 
effective pH sensors to turn on the membrane-lytic activity of mag2. Under neutral 
conditions (pH 7.0), no membrane damage was observed even at 10 M peptide 
concentration.  
 
Figure 1-18. Kinetics of peptide induced cargo (calcein) leakage. The graph shows observed 
change in calcein fluorescence at 520 nm (ex=485 nm) upon addition of peptide (3 µM) into 
LUVs of POPC (500 µM lipids, pH 7.0), followed by the addition of 6 N HCl (12 µl) to reach 
pH 5.0. 
The leakage assay demonstrated that ZpOH functions as effective pH sensors in the 
design of “smart” membrane-lytic peptides. The mag2 mutant harboring ZpOH residues 
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responds quickly to the pH drop from 7.0 to 5.0. No pH activation was observed for the 
corresponding mutant that incorporates Glu resdiues as pH sensors. This is presumably 
because the pKa value of ZpOH falls into this physiologically relevant region, while that 
of Glu does not. In addition, the hydrophobic nature of the neutral ZpOH residue allows 
their incorporation onto the membrane-binding face of a peptide, whereas all previously 
reported pH sensing elements reside on the hydrophilic face of an amphipathic structure.  
 
IV) Targeting bacterial membrane lipids  
The design of the pH-sensitive membrane-lytic peptide increases selectivity based on 
the environmental difference. In this section we will introduce an alternative strategy:  
increasing the selectivity based on the membrane composition difference. 
 
Figure 1-19. a) Structures of phospholipids. b) boronic acid based transmembrane helices chelating 
with PG 
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One significant difference between bacterial membranes and mammalian membranes 
is that bacterial membranes contain phosphatidyl-glycerol (PG) lipids (Figure 1-19a), 
which do not exist in mammalian cell membranes. Since among all the membrane lipids 
PG exclusively bears a 1,2-diol structure on its head, we can potentially incorporate 
functional groups that selectively bind diols into membrane-lytic peptides in order to 
increase the selectivity.  
Boronic acids are known to chelate with 1,2-syn-diols
[78]
, and the boronic acid 
containing amino acid Fmoc-BpinPhe-OH (compound 1-55, Scheme 1-14) was 
reportedly synthesized from Tyr and tested to chelate with the chromophoric diol 
alizarin
[79]
. Therefore, we hypothesized that magainin 2 mutants containing boronic acid 
can selectively chelate PG and bind bacterial membranes better than wild type. In other 
words, boronic acids can potentially enhance the membrane-lytic selectivity towards 
bacterial cells. Furthermore, tetrafluorinated BpinPhe (or ZpBpin, based on our naming 
system of ZpX series) is believed to chelate diols even stronger due to the electron 
deficiency
 [78]
. Although the synthesis of Fmoc-ZpBpin-OH (compound 1-14, see Section 
1.2) is still ongoing as we previously stated, we already synthesized the non-fluorinated 
Fmoc-BpinPhe-OH (compound 1-55) as the control molecule. 
 Our synthesis of Fmoc-BpinPhe-OH was carried out with a different starting material, 
Boc-protected iodophenylalanine (compound 1-43). The Miyaura borylation reaction 
between 1-43 and B2pin2 was catalyzed by PdCl2(dppf) with KOAc as base in DMSO, 
and yielded Boc-BpinPhe-OH (compound 1-44) in excellent yield (Scheme 1-14).  
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Since boronic acid pinacol 
ester is labile to hard Lewis 
bases, the Boc-Fmoc conversion 
was achieved under water-free 
conditions. Firstly, the Boc- 
group was cleaved by neat HCl 
in acetonitrile
[79]
, since the 
regular TFA condition also 
cleaved Bpin. After the cleavage 
is complete, the excess HCl was 
removed under vacuum, and the 
free amino acid H-BpinPhe-OH 
(compound 1-45) was isolated by filtration. The Fmoc-protection was carried out in 
DCM with Fmoc-Cl as the reagent, because the more often-used reagent Fmoc-OSu 
usually is only used in aqueous solutions. Since H-BpinPhe-OH is insoluble in DCM, the 
key point of this reaction is to suspend fine powders of H-BpinPhe-OH in DCM as even 
as possible, or the elimination of Fmoc-Cl will happen as a major side reaction and 
decrease the yield. The overall yield for the final product Fmoc-BpinPhe-OH (compound 
1-46) was 62% over 3 steps. 
We already have incorporated BpinPhe into magainin 2 successfully, and the assay to 
demonstrate the PG-membrane selectivity is currently underway.  
 
Scheme 1-14. Synthesis of Fmoc-BpinPhe-OH. 
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1.4 Conclusions 
 
In summary, a series of novel fluoroaromatic amino acids has been synthesized that 
can be readily utilized in the chemical synthesis of proteins. Our synthetic protocol is 
fundamentally built on the regioselective SNAr reaction of pentafluorophenylalanine Z and 
also associated with the cross-coupling reactions of ZpOTf and the diazonium chemistry 
of ZpNH2. the scope of the functional groups on the product side chains includes 
hydroxyl, alkyl/aryl, mercapto, amino and halogens. All the synthetic routes are short and 
efficient, showing no epimerizations.  
We also incorporated ZpX series amino acids into peptides and demonstrated the 
potential applications of ZpXs as indicators to detect the local environment by a 
significant shift of their 
19
F NMR signal, as halogen bonding agents to investigate novel 
non-covalent interactions, and as pH sensors to trigger highly selective membrane 
leakage. We expect the easy synthesis and unique physical properties of the ZpX series 
will make it suitable for an even wider array of applications in protein biochemistry and 
engineering.   
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Materials and Methods 
 
General Methods 
Chemicals were obtained from Fisher and Aldrich, unless otherwise indicated. Fmoc-
OSu, Rink-Amide-MBHA resin, and O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-
hexafluoro-phosphate(HBTU) were purchased from Novabiochem (San Diego, CA). All 
natural Fmoc-protected amino acids were purchased from Advanced Chemtech 
(Louisville, KL). Boc-pentafluorophenylalanine was purchased from Peptech (Burlington, 
MA). 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) was purchased from 
Avanti Polar Lipids (Alabaster, Alabama). Peptide synthesis was carried out on a Tribute 
peptide synthesizer (Protein Technologies, Tucson, AZ). 
1
HNMR and 
13
C-NMR data 
were collected on a Varian Gemini 400MHz, Varian 500 MHz and Varian 600 MHz 
NMR spectrometer. HR-MS data were generated by the Boston College Mass-Spec 
facility. The protein concentration of all samples used in this study was determined by 
measuring their absorption at 330nm on a Lambda 25 UV-Vis spectrometer (PerkinElmer, 
Waltham, MA) considering the extinction coefficient  (330nm) as 4,300 M-1 cm-1. The 
liposomes were prepared by using Liposofast Mini Extrusion system (Avanti Polar Lipids, 
Alabaster, Alabama). All fluorescence data were recorded on a Fluorolog spectrometer 
(Horiba Jobin Yvon FL3-22).  
 
Synthesis of ZpX series 
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General procedure I: Boc- deprotection 
Boc- protected amino acid (0.1 mmol) was dissolved in a mixture of 95/2.5/2.5 
TFA/
i
Pr3SiH/H2O (1 mL), and stirred at r.t. for 1 h. The solvents were then removed 
under vacuum, and the residue was directly used in general procedure II. 
 
General procedure II: Fmoc- protection 
The crude free amino acid (0.1 mmol) from General procedure I or III was dissolved 
in 10% Na2CO3 aq. (1 mL), followed by an addition of CH3CN (0.5 mL) and Fmoc-OSu 
(32 mg, 0.095 mmol). The resulting mixture was stirred vigorously at r.t. for 2.5 h, then 
poured into 1 N HCl (20 mL) and extracted with DCM (3 × 10 mL). The combined 
organic layers were washed with brine and dried over Na2SO4. After the solvent was 
evaporated under vacuum, the product was isolated with silica gel column (9:1 
toluene/HOAc).  
 
(S)-3-(4-(allyloxy)-2,3,5,6-tetrafluorophenyl)-2-(tert-butoxycarbonylamino) 
propanoic acid (1-2) 
Sodium (583 mg, 25.4 mmol) was dissolved in allyl alcohol (30 mL) in portions at 0 
o
C, followed by addition of (S)-2-(tert-butoxycarbonylamino)-3-(perfluorophenyl) 
propanoic acid (1-1, 1.0 g, 2.82 mmol). The resulting solution was sealed in a pressure 
bottle under N2 protection and stirred at 90 
o
C for 6 h. Upon cooling to room temperature, 
the reaction mixture was poured into 1N HCl (60 mL), swirled thoroughly, and extracted 
with DCM (3 × 40 ml). The combined organic layers were washed with a 10:1 mixture of 
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brine and 1N HCl and dried over Na2SO4. After the solvent was evaporated under 
vacuum, the product was isolated with silica gel column (2:1 Et2O/hexane first, to 
remove less-polar byproducts; followed by 2:1 Et2O/hexane with 2.5% HOAc).The 
product was obtained as a white crystal. Yield: 975 mg (88%). 
1
H NMR (500 MHz, 
Acetone –d6) δ: 6.27 (d, J = 8.5 Hz, 1H), 6.07 (m, 1H), 5.42 (d, J = 17.5 Hz, 1H), 5.29 (d, 
J= 5.5 Hz, 1H), 4.75 (d, J = 6.0 Hz, 2H), 4.47, (m, 1H), 3.30 (m, 1H), 3.16 (m, 1H), 1.34 
(s, 9H). 
13
C NMR (125 MHz, Acetic acid-d4) rotamers δ: 175.9, 156.9, 147.8, 145.9, 
143.3, 141.4, 137.0, 133.6, 120.0, 110.4, 81.4, 76.3, 53.6, 28.4, 26.2. 
19
F NMR (470 MHz, 
CDCl3)  δ: -146.7 (2F), -159.1 (2F). HRMS (ESI+): m/z calculated for C17H20F4NO5 [M]
+
, 
394.12776; found 394.12653. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(4-(allyloxy)-2,3,5,6-
tetrafluorophenyl)propanoic acid (1-3) 
(S)-3-(4-(allyloxy)-2,3,5,6-tetrafluorophenyl)-2-(tert-butoxycarbonylamino)propanoic 
acid (1-2) (975 mg, 2.48 mmol) was dissolved in a mixture of 95% trifluoroacetic acid, 
2.5% water and 2.5% triethylsilane (30 mL), and stirred at r.t. for 1 h. The solvents were 
then removed under vacuum, and the residue was treated with a mixture of 10% Na2CO3 
aq (30 mL), water (15 mL) and acetonitrile (25 mL) to pH~10, followed by an addition of 
Fmoc-OSu (794 mg, 2.36 mmol). The resulting solution was stirred at r.t. for 2.5 h, then 
poured into 2N HCl (60 mL), and extracted with DCM (3 × 40 ml). The combined 
organic layers were washed with a 10:1 mixture of brine and 1N HCl and dried over 
Na2SO4. After the solvent was evaporated under vacuum, the product was isolated with 
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silica gel column (2:1 Et2O/hexane first, to remove less-polar byproducts; then 9:1 
toluene/HOAc). The desired product was obtained as a white solid. Yield: 1.15 g 
(90%).
1
H NMR (500 MHz, Acetone –d6) δ: 7.81 (d, J = 7.0 Hz, 2H), 7.67 (m, 2H), 7.37 
(m, 2H), 7.29 (m, 2H), 6.94 (d, J = 9.0 Hz, 2H), 5.98 (m, 1H), 5.35 (d, J = 17.5 Hz, 1H), 
5.20, (d, J = 10.0 Hz, 2H), 4.64, (m, 3H), 4.14-4.33, (m, 3H), 3.38 (m, 1H), 3.24 (m, 1H). 
13
C NMR (125 MHz, Acetonitrile-d3) δ: 172.4, 157.0, 147.8, 145.9, 145.0, 143.3, 142.1, 
141.3, 136.8, 133.7, 128.8, 128.2, 126.2, 121.0, 120.3, 118.4, 110.8, 76.4, 67.7, 53.9, 47.9, 
26.0. 
19
F NMR (470 MHz, Acetone-d6)  δ: -144.0 (2F), -156.4 (2F). HRMS (ESI+): m/z 
calculated for C27H22F4NO5 [M]
+
, 516.14341; found 516.14489. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(2,3,5,6-tetrafluoro-4-
hydroxyphenyl)propanoic acid (1-4) 
Under N2 protection, (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(4-
(allyloxy)-2,3,5,6-tetrafluorophenyl)propanoic acid (1-3) (1.15 g, 2.25 mmol) and 
Pd(PPh3)4 (130 mg, 0.11 mmol) were dissolved in DCM (30 mL) at r.t., followed by 
addition of phenylsilane (560 μL, 4.50 mmol). The resulting solution was stirred at r.t. 
under N2 protection for 1.5 h. The reaction was quenched by 1N HCl (10 mL), and DCM 
was evaporated under vacuum. The residue was treated with 5% Na2CO3 aq to pH~8-9, 
diluted with water to a final volume of 120 mL, and then extracted with Et2O (2 × 25 ml). 
The ether layers were discarded. The pH value of the aqueous layer was tuned to 0-1 with 
2N HCl, and then extracted with EtOAc (3 × 50 ml). The combined EtOAc layers were 
dried over Na2SO4. After the solvent was evaporated under vacuum, the product was 
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isolated with silica gel column (7:1 toluene/HOAc) as a white solid. Yield: 975 mg (92%). 
1
H NMR (500 MHz, Acetone-d6) δ: 7.85 (d, J = 9.5 Hz, 2H), 7.67 (d, J = 9.0 Hz, 2H), 
7.41 (m, 2H), 7.31 (m, 2H), 6.91 (d, J = 11.5 Hz, 1H), 4.56 (m, 1H), 4.16-4.33 (m, 3H), 
3.32 (m, 1H), 3.20 (m, 1H). 
19
F NMR (470 MHz, Acetone-d6)  δ: -146.6 (2F), -164.3 (2F). 
 
(S)-methyl 3-(4-(allyloxy)-2,3,5,6-tetrafluorophenyl)-2-(tert-
butoxycarbonylamino)propanoate (1-5) 
(S)-3-(4-(allyloxy)-2,3,5,6-tetrafluorophenyl)-2-(tert-butoxycarbonylamino)propanoic 
acid (1-2) (975 mg, 2.48 mmol) was dissolved in 10 mL DMF, followed by an addition of 
K2CO3 (685 mg, 4.96 mmol) and CH3I (310 L, 4.96 mmol). The resulting suspension 
was stirred at r.t. for 16 h. Then the reaction mixture was poured into 100 mL water, 
extracted with DCM (3 × 50 mL). The combined organic layers were washed with brine 
and dried over Na2SO4. After the solvent was evaporated under vacuum, the product was 
isolated with silica gel column (4:1 hexanes/EtOAc). Yield: 859 mg (85%).  
 
(S)-methyl 2-(tert-butoxycarbonylamino)-3-(2,3,5,6-tetrafluoro-4-
hydroxyphenyl)propanoate (1-6) 
Under N2 protection, (S)-methyl 3-(4-(allyloxy)-2,3,5,6-tetrafluorophenyl)-2-(tert-
butoxycarbonylamino)propanoate (1-5) (859 mg, 2.11 mmol) and Pd(PPh3)4 (130 mg, 
0.11 mmol) were dissolved in DCM (30 mL) at r.t., followed by addition of phenylsilane 
(560 μL, 4.50 mmol). The resulting solution was stirred at r.t. under N2 protection for 1.5 
h. The reaction was quenched by 1N HCl (10 mL), and DCM was evaporated under 
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vacuum. The residue was treated with 5% Na2CO3 aq to pH~8-9, diluted with water to a 
final volume of 120 mL, and then extracted with Et2O (2 × 25 ml). The ether layers were 
discarded. The pH value of the aqueous layer was tuned to 0-1 with 2N HCl, and then 
extracted with EtOAc (3 × 50 ml). The combined EtOAc layers were dried over Na2SO4. 
After the solvent was evaporated under vacuum, the product was isolated with silica gel 
column (1:1 hexanes/EtOAc) as a white solid. Yield: 774 mg (92%). 
1
H NMR (400 MHz, 
Methanol–d4) δ: 6.91 (d, J = 8.8 Hz, 1H), 4.27 (m, 1H), 3.63 (s, 3H), 3.07 (m, 1H), 2.92 
(m, 1H), 1.27 (s, 9H). 
13
C NMR (100 MHz, Methanol-d4) δ: 171.6, 156.1, 146.9, 144.5, 
139.2, 136.7, 135.5, 104.1, 79.3, 52.9, 51.5, 27.1, 24.5. 
19
F NMR (470 MHz, Acetone-d6) 
δ: -146.9 (2F), -164.4 (2F). HRMS (ESI+): m/z calculated for C15H18F4NO5 [M]
+
, 
368.11211; found 368.11171. 
 
(S)-methyl 2-(tert-butoxycarbonylamino)-3-(2,3,5,6-tetrafluoro-4-
(trifluoromethylsulfonyloxy)phenyl) propanoate (1-7) 
Under N2 protection, (S)-methyl 2-(tert-butoxycarbonylamino)-3-(2,3,5,6-tetrafluoro-
4-hydroxyphenyl)propanoate (1-6) (135 mg,  0.37 mmol) and Et3N (0.205 mL, 1.47 
mmol)  were dissolved in anhydrous DCM (2 mL). The mixture was chilled to -78 °C and 
Tf2O (0.14 mL, 0.81 mmol) was added dropwise. The reaction was stirred at -78 °C for 
10 min and then at room temperature for another 30 min.  The reaction was quenched by 
saturated NaHCO3 aq. (30 mL) and diluted with DCM (30 mL). The organic layer was 
separated, sequentially washed with 1 N HCl and brine, and dried over Na2SO4.  After 
DCM was removed under vacuum, the product was isolated with silica gel column (5:1 
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hexanes/EtOAc) as colorless crystal. Yield: 146 mg (80%). 
1
H NMR (400 MHz, 
Chloroform–d) δ: 4.59 (m, 1H), 3.75 (s, 3H), 3.33 (m, 1H), 3.08 (m, 1H), 1.33 (s, 9H). 
13
C NMR (125 MHz, Chloroform–d) δ: 171.2, 155.1, 146.8, 144.8, 141.7, 139.7, 126.4, 
120.0, 116.4, 80.5, 52.9, 52.6, 28.1, 26.9. 
19
F NMR (470 MHz, Chloroform–d) δ: -73.0 
(3F), -140.7 (2F), -152.0 (2F). HRMS (ESI+): m/z calculated for C16H20F7N2O7S [M + 
NH4]
+
, 517.08794; found 517.08934. 
 
(S)-methyl 2-(tert-butoxycarbonylamino)-3-(2,3,5,6-tetrafluoro-3',5'-
dimethylbiphenyl-4-yl) propanoate (1-8b) 
 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(2,3,5,6-tetrafluoro-4-
(trifluoromethylsulfonyloxy)phenyl)propanoate (1-7) (50 mg, 0.10 mmol), 3,5-
dimethylphenylboronic acid (16.5 mg, 0.11 mmol), Pd(PPh3)4 (11.6 mg, 0.01 mmol) and 
K2CO3 (27.6 mg, 0.20 mmol) were dissolved in a mixture of 1,2-dimethoxyethane/water 
(6:1, 1 mL totally) and sealed in a pressure vessel under N2 protection. The reaction 
mixture was stirred at 70 °C for 12 h. Upon cooling to r.t., the reaction mixture was 
poured into 1 N HCl (15 mL) and extracted with DCM (3 × 15 mL). The combined 
organic layers were washed with brine and dried over Na2SO4. After the solvent was 
evaporated under vacuum, the product was isolated with silica gel column (5:1 
hexanes/EtOAc) as a white solid. Yield: 44 mg (95%). 
1
H NMR (500 MHz, Chloroform–
d) δ: 7.08 (s, 1H), 7.04 (s, 2H), 5.18 (d, J = 8.5 Hz, 1H), 4.66 (m, 1H), 3.80 (s, 3H), 3.39 
(m, 1H), 3.14 (m, 1H), 2.37 (s, 6H), 1.41 (s, 9H). 
13
C NMR (100 MHz, Chloroform–d) δ: 
171.7, 155.1, 146.9, 144.9, 144.6, 142.6, 139.6, 138.4, 131.0, 128.0, 120.3, 113.8, 80.4, 
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52.9, 28.4, 26.6, 21.4. 
19
F NMR (470 MHz, Chloroform–d) δ: -143.8 (2F), -144.1 (2F). 
HRMS (ESI+): m/z calculated for C23H26F4NO4 [M]
+
, 456.17980; found 456.18015. 
 
(S)-methyl 2-(tert-butoxycarbonylamino)-3-(2,3,5,6-tetrafluoro-4-
vinylphenyl)propanoate (1-8a) 
 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(2,3,5,6-tetrafluoro-4-
(trifluoromethylsulfonyloxy)phenyl)propanoate (1-7) (50 mg, 0.10 mmol), vinylboronic 
acid dibutyl ester (26.5 L, 0.12 mmol), Pd(PPh3)4 (11.6 mg, 0.01 mmol) and K2CO3 
(27.6 mg, 0.20 mmol) were dissolved in a mixture of 1,2-dimethoxyethane/water (6:1, 1 
mL totally) and sealed in a pressure vessel under N2 protection. The reaction mixture was 
stirred at 70 °C for 12 h. Upon cooling to r.t., the reaction mixture was poured into 1 N 
HCl (15 mL) and extracted with DCM (3 × 15 mL). The combined organic layers were 
washed with brine and dried over Na2SO4. After the solvent was evaporated under 
vacuum, the product was isolated with silica gel column (5:1 hexanes/EtOAc) as a white 
solid. Yield: 28 mg (74%). 
1
H NMR (500 MHz, Chloroform–d) δ: 6.67 (dd, J1 = 18.0 Hz, 
J2 = 12.0 Hz, 1H), 6.08 (d, J = 18.0 Hz, 1H), 5.69 (d, J = 12.0 Hz, 1H), 5.12 (d, J = 8.0 
Hz, 1H), 4.61 (m, 1H), 3.78 (s, 3H), 3.34 (m, 1H), 3.10 (m, 1H), 1.40 (s, 9H). 
13
C NMR 
(100 MHz, Chloroform–d) δ: 171.4, 154.9, 146.6, 145.6, 144.1, 143.0, 123.5, 122.4,  
115.9, 113.5, 80.2, 52.7, 29.7, 28.1, 26.4. 
19
F NMR (470 MHz, Chloroform–d) δ: -144.5 
(4F). HRMS (ESI+): m/z calculated for C17H20F4NO4 [M]
+
, 378.13285; found 378.13354. 
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(S)-methyl 2-(tert-butoxycarbonylamino)-3-(2,3,5,6-tetrafluoro-4-
((trimethylsilyl)ethynyl)phenyl)propanoate (1-8c) 
 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(2,3,5,6-tetrafluoro-4-
(trifluoromethylsulfonyloxy)phenyl)propanoate (1-7) (50 mg, 0.10 mmol), triethylamine 
(60 L), Pd(PPh3)4 (11.6 mg, 0.01 mmol), cuprous iodide (3.8 mg, 0.02 mmol) and 
lithium bromide (8.7 mg, 0.10 mmol) were dissolved in anhydrous THF (1 mL totally), 
followed by an addition of trimethylsilylacetylene (42 L, 0.30 mmol). The resulting 
mixture was sealed in a pressure vessel under N2 protection. The reaction mixture was 
stirred at 80 °C for 12 h. Upon cooling to r.t., the reaction mixture was poured into 1 N 
HCl (15 mL) and extracted with DCM (3 × 15 mL). The combined organic layers were 
washed with brine and dried over Na2SO4. After the solvent was evaporated under 
vacuum, the product was isolated with silica gel column (5:1 hexanes/EtOAc) as a white 
solid. Yield: 31 mg (70%). 
1
H NMR (400 MHz, Acetone-d6) δ: 6.43 (d, J = 8.4 Hz, 1H), 
4.50 (m, 1H), 3.72 (s, 3H), 3.33 (m, 1H), 3.24 (m, 1H), 1.34 (s, 9H) 0.29 (s, 9H). 
13
C 
NMR (100 MHz, Acetone-d6) δ: 172.2, 156.6, 149.4, 148.0, 146.8, 145.5, 119.5, 109.8, 
103.9, 89.8, 80.2, 54.0, 53.2, 28.8, 27.3, 0.1. 
19
F NMR (470 MHz, Chloroform–d) δ: -
140.1 (2F), -144.3 (2F). HRMS (ESI+): m/z calculated for C20H26F4NO4Si [M]
+
, 
448.15672; found 448.15521. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(2,3,5,6-tetrafluoro-3',5'-
dimethylbiphenyl-4-yl)propanoic acid (1-9b) 
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(S)-methyl 2-(tert-butoxycarbonylamino)-3-(2,3,5,6-tetrafluoro-3',5'-
dimethylbiphenyl-4-yl) propanoate (1-8b) (43 mg, 0.096 mmol) and LiOHH2O (16 mg, 
0.38 mmol) were mixed with H2O (2 mL) and THF (1 mL). The resulting suspension was 
stirred at r.t. for 16 h. Then the pH was tuned to 4-5 1 N HCl, and all the solvents were 
removed on rot. vap. The residue was directly treated sequentially as General Procedure I 
and II. Yield: 46 mg (85%). 
1
H NMR (400 MHz, Methanol–d4) δ: 7.78 (d, J = 7.6 Hz, 
2H), 7.58 (m, 2H), 7.34 (m, 2H), 7.24 (m, 2H), 7.02 (s, 1H), 6.81 (s, 2H), 4.56 (m, 1H), 
4.40 (m, 1H), 4.06-3.97 (m, 2H), 3.40 (m, 1H), 3.24 (m, 1H), 2.24 (s, 6H). 
13
C NMR (100 
MHz, Methanol–d4) δ: 176.0, 158.4, 148.4, 146.0, 145.6, 145.0, 143.8, 142.7, 142.6, 
139.4, 131.6, 128.9, 128.6, 128.4, 126.6, 126.2, 121.0, 117.0, 68.5, 55.4, 48.4, 27.5, 21.4. 
19
F NMR (376 MHz, Methanol–d4) δ: -145.4 (2F), -146.4 (2F). HRMS (ESI+): m/z 
calculated for C32H26F4NO4 [M]
+
, 564.17980; found 564.18131. 
 
(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-ethyl-2,3,5,6-
tetrafluorophenyl)propanoic acid (1-9a) 
The procedure is the same as for 1-9b. Yield: 72%.
 1
H NMR (400 MHz, Acetonitrile–
d3) δ: 7.82 (d, J = 7.6 Hz, 2H), 7.60 (d, J = 7.6 Hz, 2H), 7.41 (m, 2H), 7.33 (m, 2H), 6.17 
(d, J = 7.2 Hz, 1H), 4.48 (m, 1H), 4.30 (m, 1H), 4.25-4.10 (m, 2H), 3.28 (m, 1H), 3.16 (m, 
1H), 2.69 (q, J = 7.2 Hz, 2H), 1.15 (t, J = 7.2 Hz, 3H). 
13
C NMR (100 MHz, Acetonitrile–
d3) δ: 171.9, 156.1, 146.9, 146.1, 144.3, 144.2, 143.9, 141.5, 128.2, 127.6, 125.8, 125.7, 
121.5, 120.2, 113.9, 66.8, 53.1, 47.4, 25.7, 16.3, 13.9. 
19
F NMR (376 MHz, Methanol–d4) 
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δ: -145.5 (2F), -148.0 (2F). HRMS (ESI+): m/z calculated for C26H22F4NO4 [M]
+
, 
488.14850; found 488.14941. 
 
(S)-tert-butyl 3-(4-(allyloxy)-2,3,5,6-tetrafluorophenyl)-2-((tert-
butoxycarbonyl)amino)propanoate (1-10) 
The procedure is the same as for 1-20. Yield: 89%.
 1
H NMR (500 MHz, Chloroform–d) 
δ: 5.94 (m, 1H), 5.27 (m, 1H), 5.18 (m, 1H), 5.16 (m, 1H), 4.60 (d, J = 5.5 Hz, 2H), 4.35 
(m, 1H), 3.08 (m, 1H), 2.94 (m, 1H), 1.35 (s, 9H), 1.30 (s, 9H). 
 
(S)-tert-butyl 2-((tert-butoxycarbonyl)amino)-3-(2,3,5,6-tetrafluoro-4-
hydroxyphenyl)propanoate (1-11) 
The procedure is the same as for 1-6. Yield: 86%.
 1
H NMR (500 MHz, Chloroform–d) 
δ: 5.23 (d, J = 8.0 Hz, 1H), 4.41 (m, 1H), 3.15 (m, 1H), 2.99 (m, 1H), 1.42 (s, 9H), 1.37 
(s, 9H). 
 
(S)-tert-butyl 2-((tert-butoxycarbonyl)amino)-3-(2,3,5,6-tetrafluoro-4-
(((trifluoromethyl)sulfonyl)oxy)phenyl)propanoate (1-12) 
The procedure is the same as for 1-7. Yield: 80%.
 1
H NMR (500 MHz, Benzene–d6) δ: 
5.22 (d, J = 7.5 Hz, 1H), 4.42 (m, 1H), 2.89 (m, 1H), 2.77 (m, 1H), 1.28 (s, 9H), 1.18 (s, 
9H). 
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(S)-2-(tert-butoxycarbonylamino)-3-(2,3,5,6-tetrafluoro-4-(4-
methoxybenzylthio)phenyl)propanoic acid (1-16) 
(S)-2-(tert-butoxycarbonylamino)-3-(perfluorophenyl) propanoic acid (1-1) (200 mg, 
0.56 mmol) and (4-methoxyphenyl)methanethiol (125 L, 0.90 mmol) were dissolved in 
isopropanol (2 mL), followed by an addition of 1 N NaOH aq. (6 mL). The resulting 
solution was sealed in a pressure bottle under N2 protection and stirred at 70 
o
C for 24 h. 
Upon cooling to room temperature, the reaction mixture was poured into a mixture of 1 N 
HCl (50 mL) and 1 M CuSO4 aq. (10 mL), swirled thoroughly, and extracted with DCM 
(3 × 30 mL). The combined organic layers were washed with a 10:1 mixture of brine and 
1N HCl and dried over Na2SO4. After the solvent was evaporated under vacuum, the 
product was isolated with silica gel column (3:1 hexanes/EtOAc with 3% HOAc). Yield: 
243 mg (88%). 
1
H NMR (500 MHz, Acetone –d6) δ: 7.18 (d, J = 8.5 Hz, 2H), 6.83 (d, J = 
8.5 Hz, 2H), 6.25 (d, J = 9.0 Hz, 1H), 4.48 (m, 1H), 4.13 (s, 2H), 3.76 (s, 3H), 3.34 (m, 
1H), 3.21 (m, 1H), 1.34 (s, 9H). 
13
C NMR (125 MHz, Acetone-d6) δ: 172.8, 160.6, 156.5, 
149.0, 147.8, 147.1, 145.8, 131.3, 130.1, 118.7, 115.2, 80.0, 55.9, 53.8, 39.5, 28.8, 27.2. 
19
F NMR (470 MHz, Acetone-d6)  δ: -131.2 (2F), -138.7 (2F). HRMS (ESI+): m/z 
calculated for C22H24F4NO5S [M]
+
, 490.13113; found 490.13237. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(2,3,5,6-tetrafluoro-4-(4-
methoxybenzylthio)phenyl)propanoic acid (1-17) 
Following General Procedure I and II. The product was purified with silica gel column 
(10:1 toluene/HOAc). Yield: 80%, over 2 steps. 
1
H NMR (500 MHz, Acetone –d6) δ: 
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7.83 (d, J = 7.5 Hz, 2H), 7.66 (d, J = 7.5 Hz, 2H), 7.40 (m, 2H), 7.31 (m, 2H), 7.09 (d, J 
= 8.5 Hz, 2H), 6.92 (d, J = 9.0 Hz, 1H), 6.78 (d, J = 8.5 Hz, 2H), 4.61 (m, 1H), 4.17-4.33 
(m, 3H), 4.05 (s, 2H), 3.71 (s, 3H), 3.40 (m, 1H), 3.30 (m, 1H). 
13
C NMR (100 MHz, 
Acetone-d6) δ: 172.0, 160.2, 156.8, 149.0, 147.4, 146.6, 145.0, 144.9, 142.1, 130.9, 129.6, 
128.6, 128.0, 126.1, 120.8, 118.1, 114.7, 113.2, 67.5, 55.5, 53.8, 47.9, 39.1, 26.5. 
19
F 
NMR (470 MHz, Chloroform-d)  δ: -130.8 (2F), -138.5 (2F). HRMS (ESI+): m/z 
calculated for C32H26F4NO5S [M]
+
, 612.14678; found 612.14419. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(2,3,5,6-tetrafluoro-4-
mercaptophenyl)propanoic acid (1-18) 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(2,3,5,6-tetrafluoro-4-(4-
methoxybenzylthio)phenyl)propanoic acid (1-17) (312 mg, 0.51 mmol) was dissolved in 
a mixture of methanol (8 mL) and acetonitrile (8 mL). Hg(OAc)2 (195 mg, 0.61 mmol) 
was added. The resulting solution was stirred at 60 
o
C for 6 h in a sealed vial. Upon 
cooling to r.t., the reaction was quenched by bubbling H2S into the reaction solution over 
20 min. EtOAc (20 mL) was then added, and HgS was removed by vacuum filtration. 1N 
HCl (20 mL) was added to the filtrate, swirled thoroughly, and the organic layer was 
separated. The aqueous layer was extracted with EtOAc (2 × 30 mL), and the combined 
organic layers were dried over Na2SO4. After the solvent was evaporated under vacuum, 
the product was isolated with silica gel column (1:1 Et2O/hexane first, to remove less-
polar byproducts; followed by 9:1 toluene/HOAc). Yield: 215 mg (86%). 
1
H NMR (500 
MHz, Acetone –d6) δ: 7.81 (d, J = 7.5 Hz, 2H), 7.64 (d, J = 8.0 Hz, 2H), 7.39 (m, 2H), 
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7.29 (m, 2H), 6.95 (d, J = 8.5 Hz, 1H), 4.63 (m, 1H), 4.14-4.33 (m, 3H), 3.39 (m, 1H), 
3.28 (m, 1H). 
13
C NMR (125 MHz, Acetone –d6) δ: 172.3, 156.9, 147.5, 145.3, 145.1, 
144.9, 143.3, 142.0, 128.5, 127.9, 126.1, 114.1, 111.5, 67.5, 54.0, 47.9, 26.3. 
19
F NMR 
(470 MHz, Acetone-d6) δ: -139.7 (2F), -143.6 (2F). HRMS (ESI+): m/z calculated for 
C24H18F4NO4S [M]
+
, 492.08927; found 492.08680. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(2,3,5,6-tetrafluoro-4-
(tritylthio)phenyl)propanoic acid (1-19) 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(2,3,5,6-tetrafluoro-4-
mercaptophenyl)propanoic acid (1-18) (182 mg, 0.37 mmol) and trytl chloride (228 mg, 
0.82 mmol) were dissolved in DCM (15 mL), followed by an addition of DIPEA (135 L, 
0.82 mmol) slowly. The result mixture was stirred at r.t. for 3 h, then poured into 1% 
H3PO4 aq. (20 mL) and swirled thoroughly. The organic layer was separated, and the 
aqueous layer was extracted with DCM (20 mL). The combined organic layers were 
washed with a 10:1 mixture of brine and 1% H3PO4, and dried over Na2SO4. After the 
solvent was evaporated under vacuum, the product was isolated with silica gel column 
(2:1 hexanes/EtOAc with 2% HOAc). Yield: 230 mg (85%). 
1
H NMR (400 MHz, 
Chloroform–d) δ: 7.71 (m, 2H), 7.12-7.55 (m, 21H), 5.17 (d, J = 10.5 Hz, 1H), 4.59 (m, 
1H), 4.40 (m, 2H), 4.17 (m, 1H), 3.27 (m, 1H), 3.07 (m, 1H). 
13
C NMR (100 MHz, 
Chloroform–d) δ: 174.9, 155.7, 149.3, 146.7, 145.9, 143.7, 143.5, 143.4, 141.2, 129.7, 
127.8, 127.3, 127.0, 124.9, 120.0, 116.3, 112.8, 73.9, 67.3, 52.7, 47.0, 25.8. 
19
F NMR 
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(470 MHz, Acetone-d6) δ: -130.2 (2F), -143.6 (2F). HRMS (ESI+): m/z calculated for 
C43H31F4NO4SNa [M + Na]
+
, 756.1808; found 756.1824. 
 
(S)-tert-butyl 2-(tert-butoxycarbonylamino)-3-(perfluorophenyl)propanoate (1-20) 
t-Butyl trichloroacetimidate (4.04 mL, 22.5 mmol) was slowly added to a solution of 
(S)-2-(tert-butoxycarbonylamino)-3-(perfluorophenyl) propanoic acid (1-1) (4.0 g, 11.3 
mmol) in 120 mL DCM/cyclohexane (1:2). The resulting solution was stirred at r.t. for 16 
h. White crystal precipitated out. BF3H2O (0.22 mL) was then added, and the reaction 
was stirred at r.t. for another 1 h. The reaction was quenched with saturated NaHCO3 aq. 
(100 mL). The organic layer was separated, and the aqueous layer was extracted with 
DCM (100 mL). The combined organic layers were washed with brine and dried over 
Na2SO4. After the solvent was evaporated under vacuum, the product was isolated with 
silica gel column (9:1 hexanes/EtOAc) as white crystal. Yield: 4.4 g (95%). 
1
H NMR 
(400 MHz, Chloroform–d) δ: 5.12 (d, J = 8.8 Hz, 1H), 4.46 (m, 1H), 3.21 (m, 1H), 3.05 
(m, 1H), 1.45 (s, 9H), 1.40 (s, 9H). 
13
C NMR (100 MHz, Chloroform–d) δ: 169.9, 155.0, 
146.9, 144.5, 140.9, 138.7, 136.2, 110.9, 82.9, 79.9, 53.3, 28.1, 27.8, 26.3. 
19
F NMR (400 
MHz, Chloroform–d)  δ: -142.3 (2F), -156.5 (1F), -163.1 (2F). HRMS (ESI+): m/z 
calculated for C18H23F5NO4 [M]
+
, 412.15472; found 412.15470. 
 
(S)-tert-butyl 3-(4-azido-2,3,5,6-tetrafluorophenyl)-2-(tert-
butoxycarbonylamino)propanoate (1-21) 
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A mixture of (S)-tert-butyl 2-(tert-butoxycarbonylamino)-3-
(perfluorophenyl)propanoate (1-20) (400 mg, 0.97 mmol), tetrabutylammonium azide (28 
mg, 0.097 mmol) and NaN3 (126 mg, 1.94 mmol) in anhydrous DMF (4 mL) was sealed 
in a pressure vessel and stirred at 80 
o
C for 16 h. Upon cooling to room temperature, the 
reaction mixture was poured into saturated NaHCO3 aq. (40 mL), swirled thoroughly, and 
extracted with DCM (40 mL) and chloroform (2 × 40 mL). The combined organic layers 
were washed with brine and dried over Na2SO4. After the solvent was evaporated under 
vacuum, the product was isolated with silica gel column (6:1 hexanes/EtOAc) as white 
solid. Yield: 342 mg (81%). 
1
H NMR (400 MHz, Chloroform–d) δ: 5.11 (d, J = 7.6 Hz, 
1H), 4.44 (m, 1H), 3.22 (m, 1H), 3.03 (m, 1H), 1.45 (s, 9H), 1.40 (s, 9H). 
13
C NMR (100 
MHz, Chloroform–d) δ: 170.0, 155.1, 146.9, 144.5, 141.8, 139.3, 119.5, 111.5, 83.0, 80.2, 
53.5, 28.4, 28.1, 26.6. 
19
F NMR (400 MHz, Chloroform–d)  δ: -142.6 (2F), -153.0 (2F). 
HRMS (ESI+): m/z calculated for C18H23F4N4O4 [M]
+
, 435.16554; found 435.16337. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(4-azido-2,3,5,6-
tetrafluorophenyl)propanoic acid (1-22) 
(S)-tert-butyl 3-(4-azido-2,3,5,6-tetrafluorophenyl)-2-(tert-
butoxycarbonylamino)propanoate (1-21) was treated following General Procedure I and 
II. Yield: 85%. Known compound. 
1
H NMR (400 MHz, Methanol–d4) δ: 7.77 (d, J = 7.2 
Hz, 2H), 7.60 (m, 2H), 7.40 (m, 2H), 7.30 (m, 2H), 4.53 (m, 1H), 4.12-4.34, (m, 3H), 
3.33 (m, 1H), 3.19 (m, 1H). 
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(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(4-amino-2,3,5,6-
tetrafluorophenyl)propanoic acid (1-23) 
1,3-propanedithiol (138 L , 1.38 mmol) was added into a solution of (S)-2-(((9H-
fluoren-9-yl)methoxy)carbonylamino)-3-(4-azido-2,3,5,6-tetrafluorophenyl)propanoic 
acid (1-22) (345 mg, 0.69 mmol) and DIPEA (240 L, 1.38 mmol) in 5 mL 
methanol/acetonitrile (1:1). The resulting solution was stirred at r.t. for 5 min, then 
poured into 1N HCl (20 mL) and extracted with DCM (5 × 20 mL). The combined 
organic layers were dried over Na2SO4. DCM was evaporated under vacuum, and the 
product was isolated with silica gel column (3:2 hexanes/EtOAc, 2% HOAc) as white 
crystal. Yield: 314 mg (96%). 
1
H NMR (400 MHz, Methanol–d4) δ: 7.77 (d, J = 7.6 Hz, 
2H), 7.60 (d, J = 7.6 Hz, 2H), 7.36 (m, 2H), 7.28 (m, 2H), 4.41 (m, 1H), 4.12-4.32 (m, 
3H), 3.20 (m, 1H), 3.05 (m, 1H). 
13
C NMR (100 MHz, Methanol–d4) δ: 172.9, 156.9, 
146.7, 144.4, 143.7, 141.0, 137.5, 134.9, 127.3, 126.7, 124.8, 119.4, 100.6, 66.8, 53.6, 
24.4. 
19
F NMR (400 MHz, Acetone-d6)  δ: -148.1 (2F), -164.4 (2F). HRMS (ESI+): m/z 
calculated for C24H19F4N2O4 [M]
+
, 475.12809; found 475.12717. 
 
(S)-3-(4-azido-2,3,5,6-tetrafluorophenyl)-2-(2,2,2-trifluoroacetamido)propanoic acid 
(1-24) 
(S)-tert-butyl 3-(4-azido-2,3,5,6-tetrafluorophenyl)-2-(tert-
butoxycarbonylamino)propanoate (1-21) (300 mg, 0.69 mmol) was dissolved in TFA (2.5 
mL) at 0 
o
C. After stirred 0.5 h at 0 
o
C, trifluoroacetic anhydride (125 L, 0.90 mmol) 
was added dropwise. The resulting solution was stirred at 0 
o
C for 2 h and at r.t. for 
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another 16 h. TFA was removed under vacuum, and the residue was directly purified with 
silica gel column (9:1 toluene/HOAc). Yield: 258 mg (100%). 
1
H NMR (400 MHz, 
Methanol–d4) δ: 4.68 (m, 1H), 3.42 (m, 1H), 3.20 (m, 1H). 
13
C NMR (100 MHz, 
Methanol–d4) δ: 170.5, 157.3, 146.7, 144.3, 141.6, 139.1, 118.9, 114.4, 111.1, 51.7, 24.1. 
19
F NMR (400 MHz, Acetone-d6)  δ: -77.0 (3F), -144.9 (2F), -154.8 (2F). HRMS (ES-): 
m/z calculated for C11H4F7N4O3 [M]
-
, 373.0172; found 373.0163. 
 
(S)-3-(4-amino-2,3,5,6-tetrafluorophenyl)-2-(2,2,2-trifluoroacetamido)propanoic 
acid (1-25) 
1,3-propanedithiol (138 L , 1.38 mmol) was added into a solution of (S)-3-(4-azido-
2,3,5,6-tetrafluorophenyl)-2-(2,2,2-trifluoroacetamido)propanoic acid (1-24) (258 mg, 
0.69 mmol) and DIPEA (240 L, 1.38 mmol) in 5 mL methanol/acetonitrile (1:1). The 
resulting solution was stirred at r.t. for 5 min, then poured into 1N HCl (20 mL) and 
extracted with DCM (5 × 20 mL). The combined organic layers were dried over Na2SO4. 
DCM was evaporated under vacuum, and the product was isolated with silica gel column 
(3:2 hexanes/EtOAc, 2% HOAc) as white crystal. Yield: 228 mg (95%). 
1
H NMR (400 
MHz, Acetone –d6) δ: 8.70 (d, J = 8.4 Hz, 1H), 4.77 (m, 1H), 3.38 (m, 1H), 3.22 (m, 1H). 
13
C NMR (100 MHz, Acetone-d6) δ: 169.6, 156.5, 146.8, 144.5, 137.3, 134.9, 127.1, 
114.5, 100.0, 52.0, 23.7. 
19
F NMR (400 MHz, Acetone-d6)  δ: -77.0 (3F), -148.4 (2F), -
164.4 (2F). HRMS (ESI+): m/z calculated for C11H8F7N2O3 [M]
+
, 349.04231; found 
349.04386. 
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General procedure III: CF3CO- deprotection 
CF3CO- protected amino acid (0.1 mmol) was suspended in 1.2 N HCl (3 mL) and 
refluxed for 16 h. HCl was removed on rot. vap. And the residue was directly used in 
general procedure II. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(2,3,5,6-tetrafluoro-4-
iodophenyl)propanoic acid (1-27c) 
t-Butyl nitrite (57 L, 0.43 mmol) was added dropwise into a mixture of (S)-3-(4-
amino-2,3,5,6-tetrafluorophenyl)-2-(2,2,2-trifluoroacetamido)propanoic acid (1-25) (100 
mg, 0.287 mmol) and iodine (146 mg, 0.576 mmol) in acetonitrile (5.8 mL) at 0 
o
C. The 
resulting solution was stirred at 0 
o
C for 1.5 h. The solvent was removed on rot. vap., and 
the residue was treated with 2 M NaHSO3 (30 mL) then extracted with DCM (3 × 30 mL). 
The combined organic layers were dried over Na2SO4. DCM was evaporated under 
vacuum, and the crude product was isolated with silica gel column (9:1 toluene/HOAc) as 
a mixture of ZpI/ZpH (20:1). The ZpI/ZpH mixture was treated sequentially as General 
Procedure III and II, and finally purified with RP-HPLC (Waters Prep LC, Jupiter 10u 
C18 300A Column). Alluent condition: 70%-100% B over 20 min (Buffer A: 95% water, 
5% acetonitrile and 0.1% TFA; Buffer B: 5% water, 95% acetonitrile and 0.1% TFA). 
Yield: 114 mg (68%, over 3 steps). 
1
H NMR (400 MHz, Acetonitrile–d3) δ: 7.79 (d, J = 
7.8 Hz, 2H), 7.58 (d, J = 7.8 Hz, 2H), 7.40 (m, 2H), 7.30 (m, 2H), 6.18 (d, J = 7.8 Hz, 
1H), 4.49 (m, 1H), 4.10-4.28, (m, 3H), 3.29 (m, 1H), 3.19 (m, 1H). 
13
C NMR (100 MHz, 
Acetonitrile-d3) δ: 171.5, 156.2, 148.3, 146.4, 145.9, 144.2, 141.3, 128.0, 127.5, 127.4, 
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125.4, 120.2, 71.3, 66.9, 52.9, 47.1, 25.9. 
19
F NMR (400 MHz, Chloroform–d)  δ: -120.7 
(2F), -140.7 (2F). HRMS (ESI+): m/z calculated for C24H17F4INO4 [M]
+
, 586.01384; 
found 586.01431. 
 
General procedure IV: Sandmeyer reaction 
t-Butyl nitrite (57 L, 0.43 mmol) was added dropwise into a mixture of (S)-3-(4-
amino-2,3,5,6-tetrafluorophenyl)-2-(2,2,2-trifluoroacetamido)propanoic acid (1-25) (100 
mg, 0.287 mmol), CuX (X = Cl, Br) (0.576 mmol) and CuX2 (0.576 mmol) in acetonitrile 
(5.8 mL) at 0 
o
C. The resulting solution was stirred at 0 
o
C for 1.5 h. The solvent was 
removed on rot. vap., and the residue was treated with 1 M HCl (30 mL) then extracted 
with DCM (3 × 30 mL). The combined organic layers were dried over Na2SO4. DCM 
was evaporated under vacuum, and the crude product was isolated with silica gel column 
(9:1 toluene/HOAc) as a mixture of ZpX/ZpH, which was directly used in General 
procedure III.  
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(4-bromo-2,3,5,6-
tetrafluorophenyl)propanoic acid (1-27b) 
Following General Procedure IV, III and II. The final product was purified with RP-
HPLC (Waters Prep LC, Jupiter 10u C18 300A Column). Alluent condition: 70%-100% 
B over 20 min (Buffer A: 95% water, 5% acetonitrile and 0.1% TFA; Buffer B: 5% water, 
95% acetonitrile and 0.1% TFA). Yield: 71%, over 3 steps. 
1
H NMR (500 MHz, 
Acetonitrile–d3) δ: 7.81 (d, J = 7.5 Hz, 2H), 7.60 (d, J = 8.0 Hz, 2H), 7.40 (m, 2H), 7.32 
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(m, 2H), 6.13 (d, J = 8.0 Hz, 1H), 4.64 (m, 1H), 4.16-4.30, (m, 2H), 4.16 (m, 1H), 3.30 
(m, 1H), 3.20 (m, 1H). 
13
C NMR (100 MHz, Methanol-d4) δ: 172.0, 156.9, 146.7, 145.8, 
144.2, 143.7, 143.3, 141.0, 127.3, 126.5, 124.7, 119.3, 116.1, 97.8, 66.8, 52.8, 46.8, 25.3. 
19
F NMR (400 MHz, Chloroform–d)  δ: -133.5 (2F), -139.9 (2F). HRMS (ESI+): m/z 
calculated for C24H17BrF4NO4 [M]
+
, 538.02771; found 538.02805. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(4-chloro-2,3,5,6-
tetrafluorophenyl)propanoic acid (1-27a) 
Following General Procedure IV, III and II. The final product was purified with RP-
HPLC (Waters Prep LC, Jupiter 10u C18 300A Column). Alluent condition: 70%-100% 
B over 20 min (Buffer A: 95% water, 5% acetonitrile and 0.1% TFA; Buffer B: 5% water, 
95% acetonitrile and 0.1% TFA). Yield: 62%, over 3 steps. 
1
H NMR (500 MHz, 
Acetonitrile–d3) δ: 7.82 (d, J = 7.5 Hz, 2H), 7.60 (d, J = 8.0 Hz, 2H), 7.40 (m, 2H), 7.32 
(m, 2H), 6.13 (d, J = 8.0 Hz, 1H), 4.64 (m, 1H), 4.14-4.30, (m, 3H), 3.30 (m, 1H), 3.20 
(m, 1H). 
13
C NMR (100 MHz, Acetone-d6) δ: 171.2, 155.9, 147.0, 145.0, 144.5, 144.0, 
142.6, 141.1, 127.6, 127.1, 125.1, 119.9, 115.9, 110.0, 66.5, 53.0, 47.0, 25.5. 
19
F NMR 
(400 MHz, Chloroform–d)  δ: -141.2 (2F), -141.8 (2F). HRMS (ESI+): m/z calculated for 
C24H17ClF4NO4 [M]
+
, 494.07822; found 494.07935. 
  
(S)-2-((tert-butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)phenyl)propanoic acid (1-44) 
71 
 
(S)-2-((tert-butoxycarbonyl)amino)-3-(4-iodophenyl)propanoic acid (1-43) (2.0 g, 
5.11 mmol), B2pin2 (1.56 g, 6.14 mmol), Pd(dppf)Cl2 (112 mg, 0.15 mmol) and KOAc 
(2.0 g, 20.4 mmol) were mixed with anhydrous DMSO (25 ml) in a pressure bottle under 
N2 protection. The resulting mixture was stirred at 80 
o
C for 7 h, then poured into 1 N 
HCl (150 ml), and extracted with EtOAc (100 ml). The aqueous layer was dispensed, and 
the organic layer was washed with water (2 × 50 ml) and brine, then dried over Na2SO4. 
The product was isolated by silica gel column (hexane/EtOAc = 1:1, with 1% HOAc). 
Yield: 1.89 g (94%). 
1
H NMR (500 MHz, Chloroform–d) δ: 7.77 (d, J = 8.0 Hz, 2H), 
7.20 (d, J = 8.0 Hz, 2H), 4.90 (d, J = 8.5 Hz, 1H), 4.58 (m, 1H), 3.22 (m, 1H), 3.15 (m, 
1H), 1.42 (s, 9H), 1.36 (s, 12H). 
 
(S)-2-amino-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid 
(1-45) 
Neat HCl gas was bubbled into a solution of (S)-2-((tert-butoxycarbonyl)amino)-3-(4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid (1-44) (1044 mg, 
2.67 mmol) in anhydrous acetonitrile (20 ml) at r.t. for 2 min. The resulting solution was 
stirred at r.t. for another 30 min. The excess HCl was removed under vacuum. The 
product was isolated by filtration as white precipitate, washed with acetonitrile (2 ×), and 
dried under vacuum. Yield: 724 mg (83%). 
1
H NMR (500 MHz, D2O) δ: 7.63 (d, J = 8.0 
Hz, 2H), 7.23 (d, J = 8.0 Hz, 2H), 4.19 (t, J = 6.0 Hz, 1H), 3.23 (m, 1H), 3.13 (m, 1H), 
1.08 (s, 12H). 
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(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)phenyl)propanoic acid (1-46) 
(S)-2-amino-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid 
(1-45) (624 mg, 1.90 mmol) was suspended in a mixture of DCM (50 ml) and DIPEA 
(0.99 ml, 5.7 mmol). The suspension was chilled to 0 
o
C and added with Fmoc-Cl (492 
mg, 1.90 mmol) in portions. The reaction mixture was stirred vigorously at 0 
o
C for 0.5 h 
and at r.t. for another 1.5 h. the resulting solution was washed with 1 N HCl and brine, 
and then dried over Na2SO4. The product was isolated with silica gel column 
(hexanes/EtOAc = 3:2, with 1% HOAc). Yield: 769 mg (79%). 
1
H NMR (500 MHz, 
Acetonitrile–d3) δ: 7.82 (d, J = 8.0 Hz, 2H), 7.66 (d, J = 8.0 Hz, 2H), 7.58 (m, 2H), 7.42 
(m, 2H), 7.26-7.37 (m, 4H), 6.03 (d, J = 8.0 Hz, 1H), 4.57 (m, 1H), 4.16-4.38 (m, 3H), 
3.25 (m, 1H), 3.00 (m, 1H)1.35 (s, 12H).  
  
Conjugation of Fmoc-ZpOH-OH with (R)-(-)-3,3-Dimethyl-2-butylamine 
Under N2 protection, (S)-2-(((9H-fluoren-9-yl) methoxy)carbonylamino)-3-(2,3,5,6-
tetrafluoro-4-hydroxyphenyl)propanoic acid (1-4) (81.4mg,  0.17mmol) and HBTU 
(71.5mg 0.17mmol)  were dissolved in 0.4M DIPEA in anhydrous THF (1ml). The 
mixture was allowed to stir for 2 minutes at room temperature before the addition of (R)-
3,3-dimethyl-2-butylamine (0.27 ml,  2.0 mmol). The reaction was stirred at room 
temperature for overnight.  The reaction mixture was quenched by 1N HCl (3ml) and 
extracted with DCM (35ml). The organic layers were combined, washed with a 10:1 
mixture of brine and 1N HCl and dried over Na2SO4.  After DCM was removed under 
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vacuum, the residues were dissolved in methanol for LC_MS analysis (Figure 1-20). One 
single product was identified. m/z cal: 558.2 (M
+
)m/z obs:558.5(M
+
); 580.5 (M+Na
+
). 
The result suggested that no epimerization happened in our synthesis of Fmoc-ZpOH-OH. 
 
 
 
Figure 1-20. HPLC trace and the Mass spectrum of Conjugation product of FmocZpOH-OH with 
(R)-(-)-3,3-Dimethyl-2-butylamine 
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Marfey’s test to confirm on the stereochemistry of ZpXs 
 
Fmoc- ZpXs were deprotected with piperidine in DMF, and the free amino acids were 
isolated by Prep HPLC. The amino acids were dissolved in water to give stock solutions 
of 50 mM. Then 50 l of an amino acid stock solution was mixed with 50 l water, 20 l 
of 1 M NaHCO3 aq., and 100 l of the Marfey’s reagent (1-Fluoro-2,4-dinitrophenyl-5-L-
alanine amide, FDAA) stock solution (1% FDAA in acetone). The resulting mixture was 
incubated with gentle shaking at 35 
o
C for 1 h. The reaction was quenched by addition of 
10 l 2 N HCl. The acidified solution was diluted to 1 ml with methanol, and examined 
by LC-MS by monitoring absorption at 340 nm. For all amino acids examined, a single 
peak was observed confirming lack of epimerization. Shown below (Figure 1-21) is the 
result of ZpI as an example, only one peak was identified with the molecular weight of 
the FDAA-coupled product.  
 
Figure 1-21. HPLC trace of the Marfey’s test for Fomc-ZpI-OH.
380
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Peptide synthesis and characterization 
 
All peptides were synthesized on Rink-Amide-MBHA resin (90mg, 0.56mmol/g 
0.05mmol) using the standard Fmoc/HBTU chemistry. Five equivalents of the 
commercially available amino acids were used for the coupling reaction.  
For the ZpOH containing peptide, the incorporation of the ZpOH was accomplished 
by using three equivalents of the Fmoc-ZpOAllyl-OH and extended coupling time (1 
hour). After cleavage of the N-terminal Fmoc group from the fully protected peptide on 
the resin, a dansyl residue was incorporated by reaction of the N-terminal amino group 
with dansyl chloride (40mg, 0.15mmol) in the presence of DIPEA (52l, 0.30mmol) 
overnight. The orthogonal allyl protecting group in peptide 1 was removed by treating the 
resin-bound peptide with Pd(PPh3)4 (100mg, 0.09mmol), and PhSiH3(0.4ml, 3mmol) in 
2ml of DCM under argon protection for 3 hours, and repeated. Then the peptide was 
cleaved off the resin and deprotected fully with reagent K (80% TFA, 5% H2O, 2.5% 
EDT, 5% Thioanisole and 7.5% Phenol) at room temperature for two hours. The mixture 
was triturated three times with Et2O. The precipitate was collected and dried under 
vacuum. The crude peptides were purified by RP-HPLC (Waters Prep LC, Jupiter 10u C4 
300A Column). The identity of each peptide was confirmed by MALDI mass 
spectrometric analysis. Peptide 1, m/z cal 2962(M
+
), found 2962 (M
+
); peptide 2, m/z 
cal 2746(M
+
), found, 2746(M
+
); peptide 3, m/z cal 2644(M
+
), found 2644(M
+
).  
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For the ZpN3/ZpCl/ZpBr containing peptide 4 (for the 
19
F-
19
F cosy experiment , 
sequence: GIGKFL(ZpN3)SAKK(ZpBr)GKA(ZpCl)VGEIMNS), the incorporation of 
unnatural residues was accomplished by using three equivalents of the amino acids and 
extended coupling time (1 hour). Then the peptide was cleaved off the resin and 
deprotected fully with reagent K (80% TFA, 5% H2O, 2.5% EDT, 5% Thioanisole and 
7.5% Phenol) at room temperature for two hours. The mixture was triturated three times 
with Et2O. The precipitate was collected and dried under vacuum. The crude peptides 
were purified by RP-HPLC (Waters Prep LC, Jupiter 10u C4 300A Column). The 
identity of the peptides was confirmed by ESI mass spectrometric analysis. Peptide 4: for 
[M+3H]
3+
, m/z calculated 950.3, found 951.3; for [M+4H]
4+
, m/z calculated 713.0, found 
713.2. 
 
2D 
19
F-
19
F COSY experiment for a fluorinated magainin. 
 
The magainin mutant (peptide 4 incorporating ZpBr, ZpCl and ZpN3) was dissolved in 
90% DMSO-d6 and 10% TRIS buffer (pH = 7.4) at the final concentration of 1 mM. The 
NMR data were collected on Varian 600 MHz NMR spectrometer and shown in Figure 1-
11. 
 
19
F NMR Titration experiments for halogen bonding measurements 
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The stock solutions of pI-4F-PhCOOMe (ZpI), pH-4F-PhCOOMe (Zp) and 5F-
PhCOOMe (Z) were made as 0.05 M in anhy. cyclohexane, while pI-4F-PhCOOH (ZpI) 
and 5F-PhCOOH (Z) were dissolved to 0.05 M in water (10% D2O) at pH~10. 
The following XB pairs were tested: ZpI, Zp, Z with pyridine (Py), 1-methyl pyrrole 
(Pyr) and 1-methyl indole (indole) in cyclohexane (9 totally); and ZpI, Z with imidazole 
(Im) in water (2 totally). 
For each XB pair, 6 NMR samples with different XB acceptor concentrations (0, 0.02, 
0.1, 0.5, 1 and 2 M) were made. Each sample contains 0.025 M ZpI (or Z, Zp), various 
concentration of the XB acceptor as shown above and the total volume is 0.6 ml. For 
samples made in cyclohexanes, 1% fluorobenzene (PhF) was added as 
19
F NMR standard 
(-113.15 ppm), and cyclohexane-d12 sealed in capillary tubes was used as pseudo-internal 
deuterium lock signals. For samples made in water (10% D2O), 1% fluoroacetonitrile was 
added as NMR standard (-224.7 ppm). 
Each NMR sample was scanned 24 ct on VNMR 500 spectrometer. The chemical 
shifts of the meta-fluorine atoms were recorded and fitted as hyperbola in Origin (Figure 
1-16).  
 
Liposome preparation 
 
Buffers: 
Buffer A: 10mM TES (pH=7.0 or pH=5.0), 100mM sodium citrate;  
Buffer B: 10mM TES (pH=7.0), 100mM sodium citrate, 20mM calcein;  
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Buffer C: 10mM TES (pH=7.0), 3M guanidinium chloride, 100mM sodium citrate. 
Preparation of POPC LUVs 
A chloroform solution containing 152mg POPC was dried under reduced pressure to 
form a thin film that was mixed with 2ml Buffer A or Buffer B. After 20 cycles of 
freezing and thawing, the liposome suspension was extruded 21 times through a 100nm 
polycarbonate membrane (Liposofast Mini Extrusion system, Avanti Polar Lipid; 
Whatman Nuclepore Track-Etch Membrane) at room temperature. Free calcein was 
removed from liposome by gel filtration (ÄKTA FPLC with HiPrep
TM
 16/60 Sephacryl 
TM-S-500HR column).  The liposome hydrolyzed by Buffer A, gel filtration was used to 
separate small liposome out, making the liposome more uniform in size. The size of 
liposome was confirmed by Dynamic Light Scattering (DLS) (DynaPro nanostar, Wyatt, 
Santa Barbara, CA). All liposomes we made has a radii around 70nm and the 
polydispersity falls into the range of 15%-30%. 
 
Calcein leakage assay 
 
Peptides 1-3 were dissolved in Buffer C and concentration of the stock solutions were 
determined based on dansyl absorbance at 330nm ( = 4,300 M-1 cm-1).  The calcein 
containing POPC LUVs were diluted to a final lipid concentration of 500µM in Buffer A 
and placed into a fluorescence cell with magnetic stirring. The membrane lysis caused by 
mag2 peptides were monitored by the calcein fluorescence at 520nm (ex=485nm) on a 
fluorescence spectrometer (Horiba Jobin Yvon Fluorolog FL 3-22). During the 
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experiment, peptide stock was added into the POPC(40mM calcein) LUVs suspensiton 
with a final concentration of 3M at 1,400s, and 12l of 6N HCl was added at 5,000 s to 
tune the solution pH to 5.0, finally, 30l 10% w/v TritonX-100 was added to cause the 
total leakage at 8,600 s (Figure 1-18). 
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Thioflavin T Dimers as Novel Amyloid Ligands 
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2.1 Introduction 
 
Protein aggregation into fibrillar beta-sheet rich structures, termed amyloid, has 
been associated with an increasing number of human diseases. As a prominent 
example of this group, Alzheimer’s disease (AD) affects 4.5 million people in the 
United States and over 14 million worldwide, with most of the sufferers being people 
over 65 years of age
[1]
. The symptoms of AD include confusion, mood swings, 
troubles with language and memory loss
[2]
. Gradually, body functions are weakened 
and lost, which ultimately leads to death
[3]
. While many details of the AD pathology 
are still unknown, it is well recognized that aggregation of the amyloid beta peptide 
(A, see Figure 2-1) is a hallmark event[4]. A is processed from the amyloid 
precursor protein with a sequential cleavage by -secretase and -secretase[5], but their 
original functions are still poorly understood. A ranges from 39 to 43 amino acids, 
and the 40-residue variant (A40) is the major protein component of the plaques 
observed in the brains of AD patients
[6]
. 
  
Figure 2-1. Generation of A (left) and the formation (right) of the aggregates. 
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A aggregates can be prepared in vitro using chemically synthesized peptides. The 
monomeric A peptides assemble into oligomers, and finally turn into an extended 
fibril structure (Figure 2-2). They exhibit low nM toxicity towards neuronal cells, 
while the monomeric peptide is harmless. However, A40 aggregation usually yields 
a heterogeneous mixture of species with varying size and morphology
[7]
, and to date 
the structure-toxicity relationship of the aggregated A still remains controversial. 
Nevertheless, the collective amount of A aggregates presents an important parameter 
in all branches of research related to AD. 
 
Figure 2-2. The aggregation process of A: from monomers to the oligomers and finally the fibril 
structures. Each picture is on the scale of 1 m  1 m 
The ability of quantifying A aggregates is highly desirable for the early diagnosis 
of AD in a clinical setup, monitoring disease progression and evaluating the efficacy 
of the therapeutic drugs.  However, there is no efficient in vivo method yet, while the 
most commonly used in vitro method for amyloid detection is the thioflavin T (ThT, 
Figure 2-3) assay
[8]
. This cationic dye binds to the aggregated A40 with an apparent 
dissociation constant of ~1 M, while exhibiting no detectable binding affinity to A 
monomers. When free in aqueous solution, ThT exhibits a poor fluorescence emission. 
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Binding onto amyloid species elicits a strong fluorescence peaked at 485 nm (Figure 
2-4). The fluorescence intensity has been demonstrated to be proportional to the A 
amyloid concentration
[8]
. Though widely used in lab research, the relatively low 
amyloid binding affinity of ThT prohibits its application in monitoring A aggregates 
in the nanomolar range, which has been shown to be the relevant concentration of A  
 
Figure 2-3. Structures of ThT and its neutral analogues 
 
Figure 2-4. The fluorescence emission spectra of ThT: 1 μM ThT with/without Aβ 40 in 1 × 
buffer (0.3 M NaCl, 0.05M phosphates, pH 7.4), excitation at 440 nm, slits 6 nm, emission scan 
465-600 nm in microplate reader (50 μL each sample). 
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toxicity
[9]
. Eliminating the positive charge of ThT results in neutral analogues, named 
as the BTA series
[10]
 (Figure 2-3), which display significantly enhanced binding 
affinities to A amyloid. For example, the compound BTA-1 (Figure 2-3) binds to A 
amyloid tighter than ThT by two orders of magnitude, with an apparent Kd value of 20 
nM
[11]
. However, these molecules display no fluorescence change upon amyloid 
binding. In addition, the BTA molecules are highly hydrophobic, resulting in poor 
solubility in aqueous solutions and non-specific binding to biomolecules other than 
amyloids
[12]
. In terms of the binding mechanism, to date there is no atomic-level 
structure available for the amyloid-ThT complexes. Biochemical and spectroscopic 
data suggest that ThT and BTA-1 molecules bind A40 amyloid with its long 
dimension parallel to the amyloid fibril axis (perpendicular to the beta-strands) by 
inserting into the grooves of beta-sheet between i and i+2 side chains
[13-14]
 (Figure 
2-5). The binding is driven by hydrophobicity interactions and -stacking. Due to the 
differences in terms of the hydrophobicity and conformations, BTA-1 binds onto 
slightly different positions of A compared with ThT, but the difference is minor[15].  
Considering the binding mechanism and the highly repetitive nature of amyloid 
structures
[16]
, we hypothesized that an oligomeric construct of known amyloid ligands 
will elicit stronger association by reducing the entropic cost of binding (Figure 2-5). 
To test the hypothesis, we have synthesized a group of ThT dimers and examined their 
potentials as amyloid staining ligands.  The results show that the dimeric design 
affords significantly enhanced binding to A amyloid, with the Kd values reduced by 
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as many as 70 folds. While comparable to the BTA series in amyloid-binding affinity, 
the dimeric ThTs display dramatically enhanced fluorescence emission upon binding; 
i.e. the ThT dimers combine the attractive features of both BTA and ThT as 
fluorescent reporters of amyloid.  
 
 
 
 
 
Figure 2-5. The binding mode of ThT and BTA-1 with Aβ aggregates (top) and the hypothesis of 
the ThT dimer design (bottom) 
 
2.2 Synthesis of ThT dimer series 
 
Based on our hypothesis about the binding entropy, we designed and synthesized a 
series of ThT dimers (Scheme 2-1). The two ThT units are linked in a head-to-head 
fashion via polyethylene glycols of varying lengths. The synthesis was started with 
the hydrolysis of 2-amino-6-methoxybenzothiazole (compound 2-1) in 50% KOH aq. 
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with ethylene glycol as the co-solvent. Then compound 2-2 was condensed with 
4-dimethylaminobenzaldehyde then oxidized in DMSO to regenerate the thiazole 
heterocycle
[17]
 (compound 2-3). Compound 2-3 was efficiently demethoxylated by 
using boron tribromide in DCM to yield the 6-hydroxy derivative of BTA-2 
(compound 2-4). Coupling of the deprotonated compound 2-4 to the dimesylated 
polyethylene glycols in DMF proceeded smoothly to give the dimers of BTA-2 
(compounds 2-5a – 2-5e). Fortuitously, the dimers of BTA-2 were poorly soluble in 
DMF and precipitated out of solution once they formed. Thus, a simple filtration 
yielded the BTA-2 dimers in the pure form. Some alternative methods were also 
tested to bond the linker with compound 2-4, such as the Mitsunobu reaction, but the 
conversion was not complete due to the chemical nature of polyethylene glycol.  
 
Scheme 2-1. Synthesis of ThT dimers 
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BTA-2 dimers are poorly soluble in all kinds of common organic solvents, especially 
for 2-6a and 2-6b, which have relatively shorter linkers. After screening a series of 
solvents, nitrobenzene was found to be the only viable one for the final methylation 
step. Interestingly, methylation with excess amount of CH3I at 70 C yielded a messy 
mixture of products, yet at 120 C afforded the desired ThT dimers (2-7a – 2-7e) in 
good yields. Presumably at the lower temperature, S-methylation and N-methylation 
of the benzothiazole moiety kinetically compete and the S-methylated product further 
degrades to yield multiple side products. At the elevated temperature, N-methylation 
wins out; the resulting cationic benzothiazole prevents further alkylation on the sulfur 
atom and thus remains intact.  
Figure 2-6. Other ThT derivatives as controls  
The crude products were purified through reverse phase HPLC using a C18 
column with water/acetonitrile (with 0.1% TFA) as eluents. The HPLC purified ThT 
dimers have trifluoroacetate as the counter-ion. Coevaporation five times with dilute 
HCl solution allowed the complete conversion of the counter-ion to chloride. This 
counter-ion exchange was confirmed by 
19
F NMR. The overall yields were 17-35% 
over 5 steps. For convenience of discussion, we named the dimers as diThT-PEGn, 
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with n referring to the number of ethylene glycol units within the linker.  
With the same strategies, we also synthesized a series of control molecules, 
including an isostere of the diThT-PEG2 (diThT-C5, compound 2-7f, Figure 2-6) 
with the pentylene group as the linker instead of the PEG2 moiety, and three 
monomeric ThT derivatives with different linkers on the 6-position (MeO-ThT, 
PEG2-ThT and C5-ThT, Figure 2-6). MeO-ThT was obtained by directly methylating 
compound 2-3 and the synthesis of C5-ThT and PEG2-ThT is shown in Scheme 2-2 
(Compound 2-10a and 2-10b). The related assays about these control molecules will 
be introduced in the following sections. 
Scheme 2-2. Synthesis of C5-ThT and PEG2-ThT 
 
2.3 A40 binding affinity measurements 
 
In order to fairly compare the A binding capability between the monomeric ThT 
and the dimers, we firstly tested several physical and chemical properties of the 
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dimers to make sure they behave similarly. 
Firstly we tested the solubility of all the ThT derivatives in aqueous solution. 
According to the UV-Vis absorption data (Figure 2-7), all ThT derivatives display no 
tailing in their absorption spectra at 5 μM (dimers at 2.5 μM) except diThT PEG1, 
indicating that they are well-soluble at this concentration. Nevertheless, all the ThT 
dimers and monomers exhibit similar absorption curves (Figure 2-7) and extinction 
co-efficients values (Table 2-1). The dimerization does not affect the general optical 
properties of the ThT core. 
 
 
 
 
 
 
 
 
 
Figure 2-7. UV/Vis absorption spectra of ThT derivatives: 5 μM (dimers at 2.5 μM) of the ThT 
derivatives in 1 × buffer (0.3 M NaCl, 0.05M phosphates, pH 7.4)  
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ThT derivatives Extinction coefficient 
(at 410 nm, μM-1cm-1) 
ThT 0.0353 
diThT-PEG2 0.0458 
diThT-PEG3 0.0437 
diThT-PEG4 0.0483 
diThT-PEG5 0.0417 
diThT-PEG2-HT 0.0449 
diThT-C5 0.0446 
MeO-ThT 0.0337 
PEG2-ThT 0.0310 
C5-ThT 0.0400 
Table 2-1. Extinction coefficients of ThT derivatives 
We then compared the fluorescence characteristics of the monomers and dimers. 
The results showed that the solutions of any of the ThT monomers or dimers alone are 
essentially non-fluorescent, while upon the addition of A40, the monomers and 
dimers share similar fluorescence excitation curves (Figure 2-8), which indicates that 
the chromophores within the dimer design also behave in a similar fashion as the ThT 
monomers. 
101 
 
 
 
 
 
 
 
 
 
Figure 2-8. The fluorescence excitation spectra of ThT and diThT-PEG3: 1 μM ThT/diThT-PEG3 
+ 2 μM Aβ40 in 1 × buffer, excitation scan 320-460 nm in microplates (50 μL/sample), slits 5 nm.  
Based on the fact that the dimers and the monomers behave similarly, the 
amyloid-binding experiments of the diThTs were performed by using A40 
aggregates prepared in vitro. The A40 peptide with the wild-type sequence was 
obtained through solid phase peptide synthesis. To ensure the purity of the peptide, 
double couplings were performed for the residues after beta-branched amino acids. 
The peptide was purified through reverse phase HPLC using a C18 column.  LC-MS 
analysis confirmed the integrity of the peptide and showed the purity to be greater 
than 90%. For amyloid preparation, the purified peptide was treated following a 
reported protocol to yield fresh monomers, which were allowed to aggregate for seven 
days to completion. The resulting amyloid sample displays the characteristic 
beta-sheet signature in its circular dichroism spectrum. The amyloid sample was 
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further validated using the Congo Red binding assay
[18]
. As expected, amyloid binding 
induced a red shift in the absorption spectrum of Congo Red. The spectral shift 
allowed an estimation of the amyloid concentration, which agreed well with the A40 
monomer concentration used for amyloid preparation, assuring that all the A40 
peptides aggregated into amyloid fibrils. The details of the A40 preparation and 
characterization are introduced in the experimental section. 
The A40 binding affinities of the ThT dimers were conveniently measured 
through titration experiments, in which an increasing amount of ThT derivatives were 
titrated into solutions of A40 aggregates and the fluorescence emission spectra 
recorded. Plotting the fluorescence intensities at 485 nm against the diThT 
concentrations gave the binding curves shown in Figure 2-9. The Kd values were 
extracted by fitting these curves into a hyperbolic equation. For the monomeric ThT, a 
Kd value of 2.3 M was obtained, which agrees well with literature data
[19]
. All ThT 
dimers bind to the A40 aggregates more tightly than the monomeric ThT: the Kd 
values ranges from 0.11 to 0.034 M, corresponding to an affinity improvement of 20 
to 70 fold. Among the diThT-PEGn series, the amyloid binding affinities show a small 
(less than four fold) but reproducible variation following the order of PEG2 > PEG3 > 
PEG4  PEG5 (PEG1 was not tested due to its poor solubility). The most efficient 
dimer, diThT-PEG2, affords a Kd value of 34 nM, which is comparable to that of 
BTA-1 (Kd = 20 nM). Hence, diThT-PEG2 can be used as a potential substitute for 
BTA-1, with the added advantage of fluorescence “turn-on” upon binding onto A40 
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aggregates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-9. Binding curves of the diThTs to A40 amyloid. Top: Comparison between the 
binding curves of diThT–PEG2 and ThT demonstrating the greatly enhanced binding affinity of 
the ThT dimer. Bottom: Binding curves of the diThT–PEGn series showing the slight variation of 
the Kd values according to the linker length. 
In order to further investigate whether this observation can be explained by the 
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measuring the A40 binding affinities of the monomeric ThT derivatives featuring 
different linkers (Figure 2-10). Firstly, 6-methoxy ThT (short as MeO-ThT) yields an 
essentially identical Kd value to that of ThT, consistent with previous reports that ThT 
binding to amyloid is insensitive to the substituents on 6-position. Another derivative 
PEG2-ThT installs a PEG2 mimic, the ethoxyethoxyl group, onto the 6-position of 
ThT. The A amyloid binding test affords overlapping titration curves for PEG2-ThT 
   
 
 
 
 
 
 
 
 
 
 
 
Figure 2-10. (a) The control monomeric ThTs and the relative Kd values. (b) Binding curves of the 
monomeric ThTs to A40 amyloid. 
and ThT, indicating that the PEG2 moiety does not directly facilitate the amyloid 
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binding capabilities of the ThT monomer (Figure 2-10). Therefore, the improved 
binding affinity of diThT-PEG2 should be attributed to multivalency, which reduces 
the entropic cost of the binding event. 
 
 
 
 
 
 
 
 
Figure 2-11. A40 amyloid binding curves of diThT-C5 and diThT-PEG2 
Interestingly, C5-ThT, made as a PEG2-ThT isostere, displays an improved 
binding affinity by 3 fold, presumably due to the hydrophobic nature of the pentyl 
substituent. In addition, amyloid bound C5-ThT also yields twice as strong 
fluorescence emission (Figure 2-10). Based on this observation, we also measured the 
A40 binding affinity of diThT-C5, hoping that it may bind the amyloid even better 
than diThT-PEG2. However, it is disappointing that diThT-C5 failed to give improved 
binding affinity in comparison to diThT-PEG2. In fact, the Kd value of diThT-C5 
increased by 3 fold (Figure 2-11). One possible explanation is the hydrophobic C5 
linker tends to be buried into proteins, which introduces distortion to the binding 
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geometry of the ThT units. Although the C5 linkage does not give an improved 
amyloid binder, the result shows that the chemical nature of the linker is important. It 
remains to be seen if linkers of other chemical compositions may yield more 
favorable amyloid binders. 
 
2.4 A40 binding specificity measurements 
 
In addition to the binding affinity, the binding specificity toward A aggregates is 
essential for amyloid detection and quantification, because the samples for the 
diagnosis are usually taken from the patients’ blood or tissues, and a good detector 
ought to be able to tease out the target from the complicated background noises. 
Based on our previous conclusion, the dimers increase the binding affinity by 
inserting into the adjacent -sheet grooves, while the extended -sheet structure is 
rare in regular proteins. Therefore, the ThT dimers should only have enhanced binding 
affinity to amyloid, but not to other proteins.  
In order to prove this hypothesis, we evaluated the amyloid binding specificity of 
diThT-PEG2 and diThT-C5, and the results were compared with that of the 
monomeric ThT. Bovine serum, purchased from Sigma, was diluted 10 times (v/v) 
into a phosphate buffer and used as a blank control to evaluate the non-specific 
binding of the ThT derivatives. Small molecule solutions were prepared at 1 M ThT 
monomer concentration and the fluorescence emission spectra were collected, the 
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intensity of which are referred to as noise. We also recorded a series of fluorescence 
emission data with varying amount of A40 aggregates added, which we have 
referred to as signals.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-12. Aβ amyloid binding specificity tests for ThT (top left), dimer PEG2 (top right), 
dimer C5 (bottom left) and the signal-to-noise ratio bar graph (bottom right) . Experimental 
conditions: 1 μM ThT derivatives was mixed with various concentration of Aβ40 in 10% bovine 
serum 1 × buffer solution, excitation at 440 nm, slits 10 nm, emission scan 465-600 nm in 
microplate reader (150 μL each sample). 
Shown in Figure 2-12 are the fluorescence emission curves and the signal-to-noise 
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ratios for each ThT derivatives. It is evident that the noise levels for diThT-PEG2 and 
diThT-C5 are similar to that of the ThT monomer, i.e. the dimer design does not 
render the molecules stickier to random proteins. For monomeric ThT, the 
signal-to-noise ratio reaches 2 when 15 μM A40 aggregates are added, while both 
dimers only need less than 1.5 μM A 40 aggregates to provide the same ratio. In 
other words, the ThT dimers are more sensitive for amyloid detection and effectively 
report the presence of amyloid at concentrations at least 10 times lower than what 
monomeric ThT is able to. Also, this result further validates our previous conclusion 
that the A40 binding affinity enhancement of the ThT dimers is due to the reduced 
entropic penalty. 
 
2.5 The investigation of the binding mechanism and the “head-to-tail” dimer 
 
So far we already demonstrated that our ThT dimers are capable of serving as more 
efficient and specific A40 ligands. Now if we go back and look deeper into the 
proposed binding mechanism, in which the ThT core inserts into the grooves of 
-sheet between i and i+2 side chains (Figure 2-5), we discover that the linker of 
PEG2 spans a maximum distance of 8 Å when adopting a completely extended 
conformation, and this is not long enough to position the two ThT units in two 
adjacent grooves respectively. As a consequence, the two ThT units have to reside in 
the same groove with the opposite orientation pre-determined by the dimer design 
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(Figure 2-13).  
 
Figure 2-13. The possible binding modes for “head-to-head” and “head-to-tail” ThT dimers to 
amyloid aggregates 
If we consider the benzothiazole heterocycle as the “head” of a ThT unit, while the 
dimethylaniline part as the “tail”, then all of our previous dimers are “head-to-head” 
dimers, and the two ThT units also reside in the “head-to-head” fashion. Now it is 
very natural to imagine if the ThT unit binds to the -sheet groove with an orientation 
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preference, there has to be at least one ThT unit in the “head-to-head” dimers not 
being satisfied in terms of the orientation. In other words, a “head-to-tail” dimer, 
which can satisfy both the ThT units’ orientation preferences simultaneously, would 
have a better binding affinity compared with the “head-to-head” dimer bearing the 
same linker length (Figure 2-13).  
In order to investigate whether this orientation preference actually exits, a 
head-to-tail dimer (diThT-PEG2-HT) was synthesized harboring a six-atom linker 
connecting the aniline N atom of one monomer to the 6-C of the other (Scheme 2-3). 
 
Scheme 2-3. Synthesis of the “head-to-tail” dimer, diThT-PEG2-HT 
Starting from linking compound 2-4 with a mono TBS-protected diethylene glycol 
mesylate, the PEG2 linker was firstly coupled to the “head” of one unit (compound 
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2-11). After the deprotection of TBS-ether with TBAF in wet THF and subsequent 
oxidation with Dess-Martin periodinane, the un-linked the end of the linker was 
converted to an aldehyde (compound 2-13). On the other side, 6-methoxyl-BTA-0 
(compound 2-14) was synthesized with the previous strategy from compound 2-2 and 
4-acetylaminobenzaldehyde, followed by the hydrolysis of the acetanilide in 1.2 N 
HCl. Compounds 2-13 and 2-14 were linked together by reductive amination
[20]
, so 
the linker was coupled to the “tail” of another unit (compound 2-15). Similar to the 
previous synthesis, the final step is the methylation with methyl iodide. During the 
methylation, the secondary aniline generated from the reductive amination step was 
also methylated to tertiary aniline, making the structure of diThT-PEG2-HT more 
consistent with the “head-to-head” dimers. The whole synthesis was finished in five 
steps with an overall yield of 37%. 
However, fluorescence-based binding measurement shows that the head-to-tail 
dimer displays a slightly reduced (~ 3 fold) A amyloid binding affinity than 
diThT-PEG2 (Figure 2-14), which is not consistent with our hypothesis. Nevertheless, 
the head-to-tail dimer is still relatively favorable (by ~20 fold) compared to the ThT 
monomer in their amyloid binding affinities. This result indicates that ThT binding to 
A40 amyloid is largely determined by the shape of the flat aromatic ligand. The 
binding site does not appear to discriminate the two different orientations of the ThT 
molecules; otherwise, the head-to-tail dimer should yield much improved binding 
affinities to A amyloid as previously mentioned. 
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Figure 2-14. A40 amyloid binding curves of diThT-PEG2 and diThT-PEG2-HT 
 
2.6 Conclusions and future work 
 
In summary, we designed and evaluated a series of dimeric ThT derivatives as 
amyloid binding ligands. The dimer design affords tighter amyloid binding and retains 
the “light-up” feature in fluorescence emission upon associating with A aggregates, 
in the order of PEG2 > PEG3 > PEG4  PEG5, and the best dimer, diThT-PEG2, 
features the advantages of both ThT and BTA. The affinity gain is attributed to the 
reduced entropic cost of binding by the multivalency design. Nevertheless, the 
dimeric ThT derivatives are more specific in terms of detecting amyloid species out of 
complicated background components in the samples.  
We also designed and synthesized the “head-to-tail” ThT dimer and investigated 
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the binding mode of ThT in the amyloid -sheet grooves. The result shows that the 
“head-to-tail” dimer does not behave differently from the “head-to-head” dimer, 
indicating that there is no orientation preference in the binding process.  
Our future work is currently 
focusing on two directions. The first 
one we are working on is the 
amyloid-templated dimerization. When 
two ThT/BTA monomers bind onto the 
same -sheet groove of the amyloid, 
they can be considered to be “dragged” 
together by the amyloid and their conformation is rigidified. Hence, if the two 
monomers bear functional groups reactive with each other but suffering from high 
activation energy barrier, the reaction could be templated and then accelerated by the 
amyloid (e.g. “click chemistry between azide and alkyne[23], Figure 2-15). Since the 
ThT/BTA-amyloid binding is not covalent and reversible, the templated reactions can 
turn over and over again with very low concentration of amyloid. By measuring the 
kinetics of the templated reactions, we can potentially develop highly sensitive 
amyloid detection methods.   
We synthesized two groups of the monomers to carry out the templated reaction 
assay. One is the “click” pair, alkynyl-ThT (compound 2-20) and ThT-azide 
(compound 2-21). The synthesis is shown in Scheme 2-4.  
Figure 2-15. Amyloid-templated reaction 
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Scheme 2-4. Synthesis of alkynyl-ThT and ThT-azide 
The key step for synthesizing alkynyl-ThT is the Sonogashira coupling reaction
[24] 
between Br-ThT (compound 2-18) and TMS-acetylene, followed by a TMS cleavage 
using potassium carbonate in methanol and DCM.  
The other group for the templated reaction is the SN2 pair, BTA-1-SH (compound 
2-26a)/BTA-2-SH (compound 2-26b) and MsO-ThT (compound 2-30). As shown in 
Scheme 2-6, we synthesized the BTA-SH series from mercapto-acetic/propionic acid 
methyl ester (compound 2-22a, b). The thiol was protected with the trityl group, and 
the ester was reduced to the aldehyde by DIBAL-H. The aldehyde (compound 2-24a, 
b) was then linked onto 2-14 by reductive amination, and the trityl group was finally 
removed by TFA to yield compounds 2-26a, b. We did not methylate these two 
compounds to ThT analogues in order to have some control compounds to figure out 
if the templated reaction will be more efficient with ThT or BTA derivatives. 
Importantly, we have kept the other site, MsO-ThT (compound 2-30, Scheme 2-5) 
positively charged because, if both sites are neutral, the dimer generated from them 
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will be very poorly soluble in both water and organic solvents based on our previous 
experiences, and would not come off from the amyloid, hence stopping the turnover. 
The synthesis of MsO-ThT is slightly different, as we did the methylation first while 
leaving the mesylation as the final step. Another key point is the TBS cleavage in the 
ThT analogue, compound 2-28. It was done by refluxing the substrate with cesium 
fluoride in acetonitrile/water 9:1. The advantage of this condition is that the solvents 
can be easily evaporated, and the residue is directly used in the following mesylation 
step without further purification.  
 
Scheme 2-5. Synthesis of BTA-1-SH/BTA-2-SH and MsO-ThT 
Now we are working on the assays, trying to use LC-MS to detect the templated 
product and study the kinetics of the reaction. The optimization of these conditions is 
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currently underway. 
The other direction is to elucidate the role of ThT in extending the nematodes 
lifespan, and we are collaborating with Dr. Weerapana on this project. In 2011, 
Lithgow and co-workers published that ThT can dramatically increase the lifespan of 
Caenorhabditis elegans, a family of nematodes
[21]
. Based on this interesting discovery, 
we plan to investigate the endogenous protein targets of ThT and the mechanism to 
extend lifespan. Generally speaking, identifying the cellular protein targets of ThT in 
C. elegans will determine if this bioactivity is governed by a specific aggregating 
protein target or a particular subcellular localization, thereby serving to partially 
illuminate the role of protein aggregation in the aging process and clarify the further 
development of similar amyloid-binding small molecules as anti-aging therapeutics. 
A permanent linkage between ThT and its target is essential to increase the 
resolution of the analysis. To achieve this, our stategy is to synthesize ThT analogs 
with photo-crosslinking groups that will serve to covalently bind ThT analogues to 
their cellular protein targets in C. elegans. Also, incorporation of a bio-orthogonal 
click chemistry handle will enable enrichment for subsequent identification by mass 
spectrometry. Therefore, the synthesis will incorporate two key elements into the ThT 
scaffold: 1) a photoreactive group (e.g.  azide), which upon brief exposure of C. 
elegans to UV light (5-10 min) promotes covalent labeling of proximal proteins; and 2) 
an alkyne functionality to facilitate click chemistry-mediated conjugation of reporter 
tags for detection (rhodamine) and affinity enrichment (biotin) of labeled proteins. 
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Scheme 2-6. Synthesis of propargoxy-ThT-azide 
Propargoxy-ThT-azide (compound 2-36, Scheme 2-6) was hence obtained over 6 
steps with the similar strategies. The propargyl group was induced with propargyl 
bromide and the azido group was built up via diazonium chemistry with tert-butyl 
nitrite and TMS azide
[22]
. The C. elegans assay of propargoxy-ThT-azide and the 
following analyses are currently ongoing. 
 
 
 
 
 
 
Materials and Methods 
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General Methods 
 
All Fmoc-protected amino acids were purchased from Advanced Chemtech 
(Louisville, KY). All other chemical reagents and the bovine serum stock were 
purchased from Sigma-Aldrich (Milwaukee, WI). 96 well and 384 well microplates 
were purchased from Corning (Corning, NY). Peptide synthesis was carried out on a 
Tribute peptide synthesizer (Protein Technologies, Tucson, AZ). 
1
H-NMR and 
13
C-NMR data were collected on a Varian Gemini 400MHz NMR spectrometer. 
HR-MS data were generated by Boston College Mass-Spec facilities. Circular 
dichroism measurements were performed on an AVIV CD spectrometer (Aviv 
Biomedical Inc. Lakewood, NJ). The protein concentration of all samples used in this 
study was determined by measuring their absorption at 280 nm on a Lambda 25 
UV-Vis spectrometer (PerkinElmer, Waltham, MA). The extinction coefficient ε (280 
nm) of A40 was calculated using ExPASy ProtParam Tool 
(http://ca.expasy.org/tools/protparam.html) to be 1280 M
-1
cm
-1
. Fluorescence 
excitation and emission measurements in binding affinity tests were performed on a 
Fluorolog-3 fluorometer and a MicroMax 384 microwell plate reader (Jobin Yvon Inc. 
Edison, NJ). Fluorescence emmision measurements in binding specificity tests were 
performed on a Spectra Max M5 microwell plate reader (Molecular Devices, 
Sunnyvale, CA). 
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Synthesis of ThT derivatives 
 
2-amino-5-methoxythiophenol (2-2) 
2-amino-6-methoxybenzothiazole (10.0 g, 55.5 mmol) was suspended in 50% 
KOH aq (70 ml), and then ethylene glycol (13.5 ml) was added. The mixture was 
heated to reflux for 48h. Upon cooling to room temperature, toluene (100 ml) was 
added and then the mixture was neutralized with acetic acid (70 ml). The organic 
layer was separated, and the aqueous layer was extracted with toluene (2 ×100 ml). 
The combined organic layers were washed with water and dried over Na2SO4. The 
solvent was then evaporated under vacuum, and the residue was washed with hexanes 
to give 6.6g (77%) of 2-amino-5-methoxythiophenol as a yellow solid. 
1
H NMR (400 
MHz, DMSO-d6) δ: 6.81 (d, J = 2.8 Hz, 1H), 6.70 (d, J = 8.8 Hz, 1H), 6.49 (dd, J1 = 
8.8 Hz, J2 = 2.8 Hz, 1H), 5.60 (b, 3H), 3.62 (s, 3H).  
 
2-(4’-(Dimethylamino)phenyl)-6-methoxybenzothiazole (2-3)  
2-amino-5-methoxythiophenol (2-2) (9.85 g, 63.5 mmol) and 
4-(dimethylamino)benzaldehyde (9.60 g, 64.4 mmol) were dissolved in DMSO (80 
ml). The mixture was heated to 180 
o
C for 20 min. After cooled to room temperature, 
the reaction mixture was poured into 500 ml water. Ethyl acetate (100 ml) was then 
added and the whole mixture was stirred thoroughly. 
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2-(4’-(Dimethylamino)phenyl)-6-methoxylbenzothiazole as pale-yellowish precipitate 
was isolated by vacuum filtration, washed with ethyl acetate (3 × 10 ml) and 
anhydrous ethanol (3 × 10 ml), and dried under vacuum. Yield: 6.75g (72%). 
1
H NMR 
(400 MHz, CDCl3) δ: 7.88 (d, J = 8.8 Hz, 2H), 7.84 (d, J = 8.8 Hz, 1H), 7.30 (d, J = 
2.8 Hz, 1H), 7.01 (dd, J1 = 8.8 Hz, J2 = 2.8 Hz, 1H), 6.72 (d, J = 8.8 Hz, 2H), 3.86 (s, 
3H), 3.03 (s, 6H).  
 
2-(4’-(Dimethylamino)phenyl)-6-hydroxybenzothiazole (2-4) 
To a solution of 2-(4’-(Dimethylamino)phenyl)-6-methoxylbenzothiazole (2-3) 
(1.0g, 3.5mmol) in anhydrous DCM (100ml) was added neat BBr3 (4.6ml, 49mmol) 
dropwise at -78
 o
C under Ar protection. The reaction mixture was warmed to room 
temperature slowly and then stirred for 16 h. The reaction was quenched with water 
(100 ml) and the pH was adjusted to 4-7 with NaOH aq. 
2-(4’-(Dimethylamino)phenyl)-6-hydroxylbenzothiazole as yellowish precipitate was 
isolated by vacuum filtration, washed with water (3 × 10 ml), methanol (10 ml), DCM 
(10ml) and anhydrous ethanol (3 × 10 ml), and dried under vacuum. Yield: 0.89g 
(94%). 
1
H NMR (400 MHz, DMSO-d6) δ: 9.71 (s, 1H) 7.80 (d, J = 8.8 Hz, 2H), 7.72 
(d, J = 8.8 Hz, 1H), 7.33 (d, J = 2.4 Hz, 1H), 6.91 (dd, J1 = 8.8 Hz, J2 = 2.4 Hz, 1H), 
6.80 (d, J = 8.8 Hz, 2H), 3.01 (s, 6H).  
 
General procedure 2A: BTA-linker coupling  
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4,4'-(6,6'-(3,6,9,12-tetraoxatetradecane-1,14-diylbis(oxy))bis(benzo[d]thiazole-6,2
-diyl))bis(N,N-dimethylaniline) (2-6e; diBTA-PEG5) 
To a suspension of NaH (10.5 mg, 0.44 mmol) and anhydrous DMF (4 ml) in a 
pressure vial was added 2-(4’-(Dimethylamino)phenyl)-6-hydroxybenzothiazole (3) 
(120 mg, 0.44 mmol) in one portion. The mixture was stirred for 5 min, and hydrogen 
gas was released. Then 2,2'-(ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) 
dimethanesulfonate (2-5e) (80 mg, 0.20 mmol) was added, and the resulting mixture 
was stirred for 16 h at 90 
o
C in the screw-capped vial. The reaction mixture was then 
quenched with saturated NH4Cl aq. (5 ml), poured to water (30 ml), and extracted 
with DCM (3 × 20 ml). After the solvent was evaporated, the product was isolated 
with silica gel column (EtOAc/hexane=3:1). Yield: 123mg (82%). 
1
H NMR (400 
MHz, CDCl3) δ: 7.88 (d, J = 8.8 Hz, 4H), 7.84 (d, J = 8.8 Hz, 2H), 7.31 (d, J = 2.4 Hz, 
2H) 7.04 (dd, J1 = 8.8 Hz, J2 = 2.4 Hz, 2H), 6.72 (d, J = 8.8 Hz, 4H), 4.17 (t, J = 4.8 
Hz, 4H), 3.87 (t, J = 4.8 Hz, 4H), 3.68-3.74 (m, 8H), 3.67 (s, 4H), 3.04 (s, 12H). 
13
C 
NMR (100 MHz, CDCl3) δ: 166.7, 156.4, 152.1, 149.3, 135.9, 128.7, 122.9, 121.9, 
115.7, 111.9, 105.7, 71.1, 70.9, 70.0, 68.4, 40.4. HRMS (ESI+): m/z calculated for 
C40H47N4O6S2 [M]
+
, 743.29370; found 743.29457. 
 
4,4'-(6,6'-(ethane-1,2-diylbis(oxy))bis(benzo[d]thiazole-6,2-diyl))bis(N,N-dimethy
laniline) (2-6a; diBTA-PEG1) 
The product was directly isolated by vacuum filtration after the reaction was 
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quenched, washed with DMF (10 ml), water (3 × 10 ml), ethanol (3 × 10 ml) and 
ether (3 × 10 ml), dried under vacuum, and directly used in the followed step. Yield: 
87%. The product was insoluble in all common solvents and improper for NMR 
analysis. HRMS (ESI+): m/z calculated for C32H31N4O2S2 [M]
+
, 567.18884; found 
567.18879. 
 
4,4'-(6,6'-(2,2'-oxybis(ethane-2,1-diyl)bis(oxy))bis(benzo[d]thiazole-6,2-diyl))bis(
N,N-dimethylaniline) (2-6b; diBTA-PEG2) 
The product was directly isolated by vacuum filtration after the reaction was 
quenched, washed with DMF (10 ml), water (3 × 10 ml), ethanol (3 × 10 ml) and 
ether (3 × 10 ml), dried under vacuum, and directly used in the followed step. Yield: 
76%. The product was only slightly soluble in CDCl3 and improper for 
13
C NMR 
analysis. 
1
H NMR (400 MHz, CDCl3) δ: 7.87 (d, J = 8.8 Hz, 4H), 7.84 (d, J = 8.8 Hz, 
2H), 7.31 (d, J = 2.8 Hz, 2H) 7.04 (dd, J1 = 8.8 Hz, J2 = 2.4 Hz, 2H), 6.70 (d, J = 8.8 
Hz, 4H), 4.22 (t, J = 4.8 Hz, 4H), 3.97 (t, J = 4.8 Hz, 4H), 3.02 (s, 12H). HRMS 
(ESI+): m/z calculated for C32H31N4O2S2 [M]
+
, 611.2151; found 611.2158. 
 
4,4'-(6,6'-(2,2'-(ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(oxy)bis(benzo[d]t
hiazole-6,2-diyl))bis(N,N-dimethylaniline) (2-6c; diBTA-PEG3) 
The product was directly isolated by vacuum filtration after the reaction was 
quenched, washed with DMF (10 ml), water (3 × 10 ml), ethanol (3 × 10 ml) and 
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ether (3 × 10 ml), dried under vacuum, and directly used in the followed step. Yield: 
70%. The product was only slightly soluble in CDCl3 and improper for 
13
C NMR 
analysis. 
1
H NMR (300 MHz, CDCl3) δ: 7.86 (d, J = 9.0 Hz, 4H), 7.82 (d, J = 8.4 Hz, 
2H), 7.29 (d, J = 2.4 Hz, 2H) 7.03 (dd, J1 = 9.0 Hz, J2 = 2.7 Hz, 2H), 6.70 (d, J = 8.7 
Hz, 4H), 4.17 (t, J = 4.8 Hz, 4H), 3.89 (t, J = 4.8 Hz, 4H), 3.77 (s, 4H), 3.02 (s, 12H). 
HRMS (ESI+): m/z calculated for C36H39N4O4S2 [M]
+
, 655.24127; found 655.23766. 
 
4,4'-(6,6'-(2,2'-(2,2'-oxybis(ethane-2,1-diyl)bis(oxy))bis(ethane-2,1-diyl))bis(oxy)b
is(benzo[d]thiazole-6,2-diyl))bis(N,N-dimethylaniline) (2-6d; diBTA-PEG4) 
The product was directly isolated by vacuum filtration after the reaction was 
quenched, recrystallized with EtOAc, and directly used in the followed step. Yield: 
56%. 
1
H NMR (400 MHz, CDCl3) δ: 7.88 (d, J = 8.8 Hz, 4H), 7.84 (d, J = 8.8 Hz, 
2H), 7.30 (d, J = 2.4 Hz, 2H) 7.05 (dd, J1 = 8.8 Hz, J2 = 2.4 Hz, 2H), 6.72 (d, J = 8.8 
Hz, 4H), 4.17 (t, J = 4.8 Hz, 4H), 3.89 (t, J = 4.8 Hz, 4H), 3.71-3.76 (m, 8H), 3.04 (s, 
12H). 
13
C NMR (100 MHz, CDCl3) δ: 156.6, 152.1, 128.9, 122.7, 115.6, 112.0, 105.7, 
71.1, 70.0, 68.4, 40.5. HRMS (ESI+): m/z calculated for C40H47N4O6S2 [M]
+
, 
699.2675; found 699.2656. 
 
4,4'-(6,6'-(pentane-1,5-diylbis(oxy))bis(benzo[d]thiazole-6,2-diyl))bis(N,N-dimeth
ylaniline) (2-6f; diBTA-C5) 
The product was directly isolated by vacuum filtration after the reaction was 
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quenched, washed with DMF (10 ml), water (3 × 10 ml), ethanol (3 × 10 ml) and 
ether (3 × 10 ml), dried under vacuum, and directly used in the followed step. Yield: 
91%. The product was insoluble in all common solvents and improper for NMR 
analysis. HRMS (ESI+): m/z calculated for C38H43N4O2S2 [M]
+
,651.28274; found 
651.28372. 
 
N,N-dimethyl-4-(6-(pentyloxy)benzo[d]thiazol-2-yl)aniline (2-9a; C5-BTA) 
The product was isolated with silica gel column (EtOAc/hexane=1:4). Yield: 75%. 
1
H NMR (400 MHz, CDCl3) δ: 7.81 (d, J = 9.2 Hz, 2H), 7.77 (d, J = 8.8 Hz, 1H), 7.20 
(d, J = 2.8 Hz, 1H) 6.93 (dd, J1 = 8.8 Hz, J2 = 2.8 Hz, 1H), 6.63 (d, J = 9.2 Hz, 2H), 
3.91 (t, J = 4.8 Hz, 2H), 2.93 (s, 6H), 1.73 (m, 2H), 1.30-1.37 (m, 4H), 0.86 (t, J = 4.8 
Hz, 3H). 
13
C NMR (100 MHz, CDCl3) δ: 166.4, 156.7, 152.0, 148.9, 135.9, 128.6, 
122.8, 121.8, 115.5, 111.9, 105.2, 68.8, 40.4, 29.2, 28.4, 22.7, 14.3. HRMS (ESI+): 
m/z calculated for C20H25N2OS [M]
+
,341.1687; found 341.1689. 
 
4-(6-(2-ethoxyethoxy)benzo[d]thiazol-2-yl)-N,N-dimethylaniline (2-9b; 
PEG2-BTA) 
The product was isolated with silica gel column (EtOAc/hexane=1:3). Yield: 76%. 
1
H NMR (400 MHz, CD2Cl2) δ: 7.81 (d, J = 9.2 Hz, 2H), 7.74 (d, J = 8.8 Hz, 1H), 
7.27 (d, J = 2.4 Hz, 1H) 6.97 (dd, J1 = 9.2 Hz, J2 = 2.8 Hz, 1H), 6.66 (d, J = 9.2 Hz, 
2H), 4.07 (m, 2H), 3.71 (m, 2H), 3.51 (q, J = 7.2 Hz, 2H), 2.95 (s, 6H), 1.16 (t, J = 7.2 
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Hz, 3H). 
13
C NMR (100 MHz, CD2Cl2) δ: 166.3, 156.5, 152.1, 149.2, 135.9, 128.4, 
122.7, 121.6, 115.4, 111.8, 105.4, 69.1, 68.4, 66.9, 40.1, 15.2. HRMS (ESI+): m/z 
calculated for C19H23N2O2S [M]
+
,343.1480; found 343.1483. 
 
4-(6-(2-(2-(tert-butyldimethylsilyloxy)ethoxy)ethoxy)benzo[d]thiazol-2-yl)-N,N-di
methylaniline (2-11) 
The product was isolated with silica gel column (EtOAc/hexane=1:3). Yield: 91%. 
1
H NMR (400 MHz, CDCl3) δ: 7.87 (d, J = 8.8 Hz, 2H), 7.84 (d, J = 9.2 Hz, 1H), 7.29 
(d, J = 2.8 Hz, 1H) 7.04 (dd, J1 = 8.8 Hz, J2 = 2.4 Hz, 1H), 6.68 (d, J = 9.2 Hz, 2H), 
4.14 (t, J = 4.8 Hz, 2H), 3.86 (t, J = 4.8 Hz, 2H), 3.79 (t, J = 5.2 Hz, 2H), 3.63 (t, J = 
5.2 Hz, 2H), 2.98 (s, 6H), 0.88 (s, 9H), 0.07 (s, 6H). 
13
C NMR (100 MHz, CDCl3) δ: 
166.5, 156.3, 151.9, 149.1, 135.8, 128.5, 122.7, 121.6, 115.5, 111.8, 105.4, 73.0, 69.9, 
68.3, 62.9, 40.2, 26.1, 18.5, -5.1. HRMS (ESI+): m/z calculated for C25H37N2O3SiS 
[M]
+
, 473.2294; found 473.2295.  
 
2-(2-(2-(4-(dimethylamino)phenyl)benzo[d]thiazol-6-yloxy)ethoxy)ethanol (2-12) 
4-(6-(2-(2-(tert-butyldimethylsilyloxy)ethoxy)ethoxy)benzo[d]thiazol-2-yl)-N,N-di
methylaniline (2-11) (302 mg, 0.64 mmol) was dissolved in 1 M TBAF in THF (5% 
water) (1 ml, 1.0 mmol) and stirred for 1 h at rt. The reaction was quenched with 
water, extracted with DCM (3 × 15 ml), and the combined organic layers were dried 
over Na2SO4. The product was isolated with silica gel column (EtOAc/hexane=1:5). 
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Yield: 206 mg (90%). 
1
H NMR (400  MHz, DMSO-d6) δ: 7.83 (d, J = 9.2 Hz, 2H), 
7.81 (d, J = 9.2 Hz, 1H), 7.64 (d, J = 2.4 Hz, 1H), 7.07 (dd, J1 = 9.2 Hz, J2 = 2.4 Hz, 
1H), 6.81 (d, J = 8.8 Hz, 2H), 4.64 (t, J = 9.2 Hz, 1H), 4.17 (m, 2H), 3.78 (m, 2H), 
3.52 (m, 4H) 3.01 (s, 6H). 
13
C NMR (100 MHz, DMSO-d6) δ: 165.3, 155.9, 151.8, 
148.2, 135.1, 128.0, 122.3, 120.4, 115.5, 111.8, 105.6, 72.4, 68.8, 67.8, 60.2. 
High-resolution mass spectrometry (HRMS) (ESI+): m/z calculated for C19H23N2O3S1 
[M]
+
, 359.14294; found 359.14300. 
 
2-(2-(2-(4-(dimethylamino)phenyl)benzo[d]thiazol-6-yloxy)ethoxy)acetaldehyde 
(2-13) 
To a solution of 
2-(2-(2-(4-(dimethylamino)phenyl)benzo[d]thiazol-6-yloxy)ethoxy)ethanol (2-12) (88 
mg, 0.24 mmol) in DCM (5 ml) was added Dess-Martin periodinane (126 mg, 0.29 
mmol) in one portion. The mixture was stirred at rt for 2 h. The reaction was 
quenched with sat. NaHCO3 and Na2S2O3, the organic layer was separated, and the 
aqueous layer was extracted with DCM (2 × 15 ml). The combined organic layers 
were washed with brine and dried over Na2SO4. After the solvent was evaporated, the 
product was isolated with silica gel column (EtOAc/hexane=3:1). Yield: 63 mg (72%). 
1
H NMR (400 MHz, CDCl3) δ: 9.75 (d, J = 0.4 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.86 
(d, J = 8.8 Hz, 1H), 7.32 (d, J = 2.4 Hz, 1H), 7.04 (dd, J1 = 8.8 Hz, J2 = 2.4 Hz, 1H), 
6.72 (d, J = 8.8 Hz, 2H), 4.25 (s, 2H), 4.22 (t, J = 4.8 Hz, 2H), 3.95 (t, J = 4.8 Hz, 2H), 
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3.03 (s, 6H). 
13
C NMR (100 MHz, CDCl3) δ: 200.5, 156.1, 152.1, 149.4, 135.9, 128.7, 
122.3, 121.7, 115.4, 111.9, 105.6, 76.9, 70.6, 68.4, 40.4, 29.9. HRMS (ESI+): m/z 
calculated for C19H21N2O3S1 [M]
+
, 357.12729; found 357.12885. 
 
4-(6-(2-(2-(4-(6-methoxybenzo[d]thiazol-2-yl)phenylamino)ethoxy)ethoxy)benzo[
d]thiazol-2-yl)-N,N-dimethylaniline (2-15) 
To a solution of 
2-(2-(2-(4-(dimethylamino)phenyl)benzo[d]thiazol-6-yloxy)ethoxy)acetaldehyde 
(2-13) (44mg, 0.13 mmol) and 4-(6-methoxybenzo[d]thiazol-2-yl)aniline (2-14) (40 
mg, 0.16 mmol) in anhydrous 1,2-dichloroethane (10 ml) was added NaBH(OAc)3 (40 
mg, 0.19 mmol). The mixture was stirred at rt for 24 h. Precipitate was generated 
gradually. The reaction was quenched with sat. NaHCO3, and the whole mixture was 
filtered. The filtrate (product) was washed with water, MeOH and ether, dried under 
vacuum, and directly used in the followed step without further purification. 
 
General procedure 2B: methylation of BTA derivatives.  
6,6'-(3,6,9,12-tetraoxatetradecane-1,14-diylbis(oxy))bis(2-(4-(dimethylamino)phe
nyl)-3-methylbenzo[d]thiazol-3-ium) chloride (2-7e; diThT-PEG5) 
4,4'-(6,6'-(3,6,9,12-tetraoxatetradecane-1,14-diylbis(oxy))bis(benzo[d]thiazole-6,2-
diyl))bis(N,N-dimethylaniline) (2-6e) (56 mg, 0.075 mmol), MeI (94 μl, 1.5 mmol) 
and nitrobenzene (2ml) were mixed in a pressure vial and stirred 48 h at 110 
o
C. The 
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solvent was evaporated under vacuum, and the residue was dissolved in DMSO (5 ml), 
filtered, and purified on HPLC. The isolated product was anion-exchanged with 1 M 
HCl in methanol (5 × 20 ml) and lyophilized. Yellow solid was finally obtained. Yield: 
44 mg (69%). 
1
H NMR (400 MHz, CD3CN) δ: 7.88 (d, J = 9.6 Hz, 2H), 7.69 (d, J = 
9.2 Hz, 4H), 7.64 (d, J = 2.4 Hz, 2H), 7.39 (dd, J1 = 9.2 Hz, J2 = 2.4 Hz, 2H), 6.90 (d, 
J = 9.2 Hz, 4H), 4.22 (t, J = 4.8 Hz, 4H), 4.13 (s, 6H), 3.84 (t, J = 4.8 Hz, 4H), 
3.58-3.66 (m, 8H), 3.57 (s, 4H), 3.12 (s, 12H). 
13
C NMR (100 MHz, CD3CN) δ: 173.5, 
160.1, 155.5, 138.5, 133.4, 131.3, 120.2, 113.3, 112.2, 108.2, 71.8, 71.6, 70.4, 70.1, 
40.8, 39.6. HRMS (ESI+): m/z calculated for C42H52N4O6S2 [M]
+
,386.1658; found 
386.1668. 
 
6,6'-(ethane-1,2-diylbis(oxy))bis(2-(4-(dimethylamino)phenyl)-3-methylbenzo[d]t
hiazol-3-ium) chloride (2-7a; diThT-PEG1) 
Yield: 63%. 
1
H NMR (400 MHz, CD3CN) δ: 7.93 (d, J = 9.2 Hz, 2H), 7.74 (d, J = 
2.4 Hz, 2H), 7.71 (d, J = 8.8 Hz, 4H), 7.45 (dd, J1 = 9.2 Hz, J2 = 2.4 Hz, 2H), 6.93 (d, 
J = 8.8 Hz, 4H), 4.54 (s, 4H), 4.16 (s, 6H), 3.13 (s, 12H). 
13
C NMR (100 MHz, 
CD3CN) δ: 173.8, 159.8, 155.5, 138.9, 133.5, 131.4, 120.2, 113.4, 112.3, 108.4, 69.0, 
40.8, 39.6. HRMS (ESI+): m/z calculated for C34H36N4O2S2 [M]
+
,298.1134; found 
298.1140. 
 
6,6'-(2,2'-oxybis(ethane-2,1-diyl)bis(oxy))bis(2-(4-(dimethylamino)phenyl)-3-met
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hylbenzo[d]thiazol-3-ium) chloride (2-7b; diThT-PEG2) 
Yield: 63%. 
1
H NMR (400 MHz, CD3CN) δ: 7.88 (d, J = 9.2 Hz, 2H), 7.67 (d, J = 
9.2 Hz, 4H), 7.64 (d, J = 2.4 Hz, 2H), 7.40 (dd, J1 = 9.2 Hz, J2 = 2.4 Hz, 2H), 6.90 (d, 
J = 9.6 Hz, 4H), 4.28 (t, J = 4.4 Hz, 4H), 4.13 (s, 6H), 3.94 (t, J = 4.4 Hz, 4H), 3.12 (s, 
12H). 
13
C NMR (100 MHz, CD3CN) δ: 173.5, 160.1, 155.4, 138.6, 133.4, 131.2, 
120.1, 113.3, 112.2, 108.2, 70.7, 70.1, 40.8, 39.6. HRMS (ESI+): m/z calculated for 
C36H40N4O3S2 [M]
+
,320.1265; found 320.1275. 
 
6,6'-(2,2'-(ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(oxy)bis(2-(4-(dimethyl
amino)phenyl)-3-methylbenzo[d]thiazol-3-ium) chloride (2-7c; diThT-PEG3) 
Yield: 59%. 
1
H NMR (400 MHz, CD3CN) δ: 7.88 (d, J = 9.2 Hz, 2H), 7.66 (d, J = 
8.8 Hz, 4H), 7.64 (d, J = 2.4 Hz, 2H), 7.39 (dd, J1 = 9.2 Hz, J2 = 2.4 Hz, 2H), 6.89 (d, 
J = 9.2 Hz, 4H), 4.22 (t, J = 4.4 Hz, 4H), 4.13 (s, 6H), 3.86 (t, J = 4.8 Hz, 4H), 3.70 (s, 
4H), 3.11 (s, 12H). 
13
C NMR (100 MHz, CD3CN) δ: 172.2, 158.9, 154.2, 137.3, 132.2, 
130.0, 119.0, 112.1, 111.0, 106.9, 70.6, 69.2, 68.9, 39.6, 38.3. HRMS (ESI+): m/z 
calculated for C38H44N4O4S2 [M]
+
,342.1396; found 342.1405. 
 
6,6'-(2,2'-(2,2'-oxybis(ethane-2,1-diyl)bis(oxy))bis(ethane-2,1-diyl))bis(oxy)bis(2-(
4-(dimethylamino)phenyl)-3-methylbenzo[d]thiazol-3-ium) chloride (2-7d; 
diThT-PEG4)  
Yield: 62%. 
1
H NMR (400 MHz, DMSO-d6) δ: 8.14 (d, J = 9.2 Hz, 2H), 7.97 (d, J 
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= 2.4 Hz, 2H), 7.77 (d, J = 9.2 Hz, 4H), 7.47 (dd, J1 = 9.2 Hz, J2 = 2.4 Hz, 2H), 6.96 
(d, J = 9.2 Hz, 4H), 4.22 (m, 4H), 4.20 (s, 6H), 3.82 (m, 4H), 3.58-3.63 (m, 8H), 3.12 
(s, 12H). 
13
C NMR (100 MHz, DMSO-d6) δ: 171.6, 158.4, 154.0, 137.3, 132.4, 130.0, 
119.0, 118.1, 112.4, 111.2, 107.3, 70.3, 69.1, 68.8, 38.5. HRMS (ESI+): m/z calculated 
for C40H48N4O5S2 [M]
+
,364.1527; found 364.1534. 
 
6,6'-(pentane-1,5-diylbis(oxy))bis(2-(4-(dimethylamino)phenyl)-3-methylbenzo[d]
thiazol-3-ium) chloride (2-7f; diThT-C5) 
Yield: 67%. 
1
H NMR (400 MHz, DMSO-d6) δ: 8.15 (d, J = 9.6 Hz, 2H), 7.97 (d, J 
= 2.8 Hz, 2H), 7.79 (d, J = 8.8 Hz, 4H), 7.47 (dd, J1 = 8.8 Hz, J2 = 2.4 Hz, 2H), 6.97 
(d, J = 9.2 Hz, 4H), 4.21 (s, 6H), 4.17 (t, J = 6.4 Hz, 4H), 3.12 (s, 12H), 1.90 (m, 4H), 
1.65 (m, 2H). 
13
C NMR (100 MHz, CD3CN) δ: 160.3, 155.4, 138.4, 133.4, 131.4, 
120.2, 113.3, 112.3, 107.9, 70.4, 40.8, 39.5, 29.8, 23.6. HRMS (ESI+): m/z calculated 
for C37H42N4O2S2 [M]
+
,319.1369; found 319.1378.  
 
2-(4-(dimethylamino)phenyl)-3-methyl-6-(pentyloxy)benzo[d]thiazol-3-ium 
chloride (2-10a; C5-ThT) 
Yield: 71%. 
1
H NMR (400 MHz, DMSO-d6) δ: 8.14 (d, J = 9.6 Hz, 1H), 7.97 (d, J 
= 2.4 Hz, 1H), 7.79 (d, J = 8.8 Hz, 2H), 7.44 (dd, J1 = 9.2 Hz, J2 = 2.4 Hz, 1H), 6.96 
(d, J = 9.2 Hz, 2H), 4.21 (s, 3H), 4.11 (t, J = 6.4 Hz, 2H), 3.11 (s, 6H), 1.79 (m, 2H), 
1.40 (m, 4H), 0.91 (t, J = 6.8 Hz, 3H). 
13
C NMR (100 MHz, DMSO-d6) δ: 171.1, 
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158.1, 153.4, 136.7, 131.9, 129.7, 118.4, 117.7, 111.9, 111.0, 107.0, 68.6, 38.2, 28.1, 
27.6, 21.9, 13.9. HRMS (ESI+): m/z calculated for C21H27N2OS [M]
+
,355.1838; found 
355.1837. 
 
2-(4-(dimethylamino)phenyl)-6-(2-ethoxyethoxy)-3-methylbenzo[d]thiazol-3-ium 
chloride (2-10b; PEG2-ThT) 
Yield: 70%. 
1
H NMR (400 MHz, CD3CN) δ: 7.89 (d, J = 9.2 Hz, 1H), 7.70 (d, J = 
9.2 Hz, 2H), 7.66 (d, J = 2.0 Hz, 1H), 7.41 (dd, J1 = 9.2 Hz, J2 = 2.4 Hz, 1H), 6.91 (d, 
J = 9.6 Hz, 2H), 4.23 (m, 2H), 4.15 (s, 3H), 3.80 (m, 2H), 3.56 (q, J = 8.8 Hz, 2H), 
3.12 (s, 6H), 1.18 (t, J = 6.8 Hz, 3H). 
13
C NMR (100 MHz, CDCl3) δ: 171.6, 159.3, 
154.2, 136.9, 132.1, 129.7, 119.7, 117.3, 112.4, 110.8, 106.7, 68.9, 68.7, 67.0, 58.8, 
40.2, 38.6, 23.9. HRMS (ESI+): m/z calculated for C20H25N2O2S [M]
+
,357.1631; 
found 357.1642. 
 
2-(4-(dimethylamino)phenyl)-6-(2-(2-((4-(6-methoxy-3-methylbenzo[d]thiazol-3-i
um-2-yl)phenyl)(methyl)amino)ethoxy)ethoxy)-3-methylbenzo[d]thiazol-3-ium 
chloride (2-16, diThT-PEG2-HT) 
Yield: 64% from (2-14). 
1
H NMR (400 MHz, DMSO-d6) δ: 8.15 (m, 2H), 7.94 (m, 
2H), 7.78 (m, 4H), 7.46 (m, 2H), 6.95 (m, 4H), 4.20-4.24 (m, 7H), 3.90-3.91 (m, 3H), 
3.85 (m, 2H), 3.74 (s, 3H), 3.11 (m, 11H). 
13
C NMR (100 MHz, DMSO-d6) δ: 171.1, 
171.0, 158.8, 158.0, 153.4, 152.7, 136.9, 136.8, 131.9, 129.7, 129.6, 118.3, 118.2, 
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117.8, 112.0, 111.9, 111.0, 110.9, 107.2, 106.4, 68.8, 68.2, 67.9, 56.2, 56.1, 51.1, 38.2. 
HRMS (ESI+): m/z calculated for C40H47N4O6S2 [M]
+
,320.1265; found 320.1259.  
 
N,N-dimethyl-4-(6-((trimethylsilyl)ethynyl)benzo[d]thiazol-2-yl)aniline (2-19) 
A mixture of 4-(6-bromobenzo[d]thiazol-2-yl)-N,N-dimethylaniline (53 mg, 0.16 
mmol), Pd(PPh3)2Cl2 (5.6 mg, 8 mol), CuI (3.0 mg, 16 mol), PPh3 (8.3 mg, 32 
mol), trimethylsilylacetylene (27 l, 0.19 mmol) and piperidine (22 l, 0.22 mmol) 
in anhydrous DMF (2 ml) was stirred in a pressure vial under N2 protection at 120 
o
C 
for 2 h. After cooled to r.t., the resulting solution was treated with Et2O (20 ml). Grey 
precipitate was formed and removed by filtration. The supernatant was sequentially 
washed with 2 N HCl, sat. NaHCO3 aq. and brine, and then dried over Na2SO4. The 
product was purified with silica gel column. Yield: 40 mg (72%). 
1
H NMR (400 MHz, 
Chloroform-d) δ: 7.93 (d, J = 1.6 Hz, 1H), 7.91 (d, J = 9.2 Hz, 2H), 7.84 (d, J = 8.4 
Hz, 1H), 7.49 (dd, J1 = 8.4 Hz, J2 = 1.6 Hz, 1H), 6.71 (d, J = 9.2 Hz, 2H), 3.04 (s, 6H), 
0.24 (s, 9H). 
 
2-(4-(dimethylamino)phenyl)-6-ethynyl-3-methylbenzo[d]thiazol-3-ium (2-20) 
A suspension of 
N,N-dimethyl-4-(6-((trimethylsilyl)ethynyl)benzo[d]thiazol-2-yl)aniline (2-19) (52 
mg, 0.15 mmol) and K2CO3 (205 mg, 1.5 mmol) in DCM (1.5 ml) and methanol (6 ml) 
was stirred vigorously at r.t. for 1 h. The solvents were then removed under vacuum. 
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The product was isolated with silica gel column (hexane/EtOAc = 6:1), and then 
treated as general procedure 2B. Yield: 41% from 2-19. 
1
H NMR (500 MHz, 
Methanol-d4) δ: 8.34 (d, J = 1.5 Hz, 1H), 8.11 (d, J = 9.0 Hz, 2H), 7.94 (d, J = 9.0 Hz, 
1H), 7.87 (dd, J1 = 9.0 Hz, J2 = 1.5 Hz, 1H), 7.05 (d, J = 9.2 Hz, 2H), 4.33 (s, 3H), 
3.22 (s, 6H). 
 
2-(4-azidophenyl)-6-methoxy-3-methylbenzo[d]thiazol-3-ium (2-21) 
4-(6-methoxybenzo[d]thiazol-2-yl)aniline (2-14) was treated with the same 
procedure for 2-35, then followed general procedure 2B. Yield: 51%. 
1
H NMR (400 
MHz, Chloroform-d) δ: 8.02 (d, J = 9.2 Hz, 1H), 7.84 (d, J = 8.8 Hz, 2H), 7.55 (d, J = 
2.4 Hz, 1H), 7.44 (dd, J1 = 9.2 Hz, J2 = 2.4 Hz, 1H), 7.32 (d, J = 8.8 Hz, 2H), 4.36 (m, 
3H), 3.97 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ: 170.3, 160.9, 146.9, 136.6, 132.2, 
131.4, 120.8, 118.2, 117.5, 114.6, 105.5, 56.6, 38.4.  
 
methyl 2-(tritylthio)acetate (2-23a) 
DIPEA (1.04 ml, 6 mmol) was added slowly to a solution of methyl 
2-mercaptoacetate (2-22a) (0.40 ml, 4.5 mmol) and trityl chloride (0.84 g, 3.0 mmol) 
in DCM (20 ml). The resulting solution was stirred at r.t. for 2 h. 1 M NaOH (20 ml) 
was added to the reaction mixture. The organic layer was separated, washed with 1 M 
NaOH (10 ml) and dried over Na2SO4. The product was isolated with silica gel 
column (hexanes/EtOAc = 20:1). Yield: 1.05 g (67%). 
1
H NMR (400 MHz, 
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Chloroform-d) δ: 7.1-7.4 (m, 15H), 3.57 (s, 3H), 2.98 (s, 2H). 
 
methyl 3-(tritylthio)propanoate (2-23b) 
The procedure is the same as for compound 2-23a. Yield: 65%. 
1
H NMR (300 
MHz, Chloroform-d) δ: 7.1-7.5 (m, 15H), 3.63 (s, 3H), 2.46 (t, J = 7.2 Hz, 2H), 2.24 
(t, J = 7.2 Hz, 2H). 
 
2-(tritylthio)acetaldehyde (2-24a) 
DIBAL (1 ml, 1.5 M in toluene) was added dropwise to a stirred solution of 2-23a 
(240 mg, 0.69 mmol) in anhydrous DMF (5 ml) under N2 protection at -78 
o
C. The 
reaction was stirred for another 30 min at -78 
o
C, quenched with methanol (5 ml), and 
added with 1 M Rochelle’s salt solution (10 ml). After warmed to r.t., the resulting 
mixture was added with ether (20 ml) and shaken vigorously. The organic layer was 
separated, and the aqueous layer was extracted with ether (2  15 ml). The combined 
organic layers were washed with brine and dried over Na2SO4. The product was 
isolated with silica gel column (hexanes/EtOAc = 20:1). Yield: 140 mg (63%). 
1
H 
NMR (400 MHz, Chloroform-d) δ: 8.84 (t, J = 2.8 Hz, 1H), 7.2-7.5 (m, 15H), 3.09 (d, 
J = 2.8 Hz, 2H). 
 
3-(tritylthio)propanal (2-24b) 
The procedure is the same as for compound 2-24a. Yield: 53%. 
1
H NMR (300 
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MHz, Chloroform-d) δ: 9.55 (s, 1H) 7.2-7.5 (m, 15H), 2.3-2.5 (m, 4H). 
 
4-(6-methoxybenzo[d]thiazol-2-yl)-N-(2-(tritylthio)ethyl)aniline (2-25a) 
Compounds 2-14 (98 mg, 0.37 mmol) and 2-24a (112 mg, 0.35 mmol) were 
dissolved in 1,2-dichloroethane (7 ml), and treated with NaBH(OAc)3 (112 mg, 0.53 
mmol). The resulting solution was stirred at r.t. for 4 h. The reaction was quenched 
with sat. NaHCO3 (10 ml). the organic layer was separated, and the aqueous layer was 
extracted with DCM (2  15 ml). The combined organic layers were washed with 
brine and dried over Na2SO4. The product was isolated with silica gel column 
(hexanes/EtOAc = 4:1). Yield: 92 mg (47%). 
1
H NMR (400 MHz, Chloroform-d) δ: 
7.86 (d, J = 8.8 Hz, 1H), 7.79 (d, J = 8.4 Hz, 2H), 7.2-7.5 (m, 16H), 7.04 (dd, J1 = 8.8 
Hz, J2 = 2.0 Hz, 1H), 6.45 (d, J = 8.4 Hz, 2H), 3.88 (s, 3H), 3.07 (m, 2H), 2.05 (t, J = 
4.8 Hz, 2H). 
 
4-(6-methoxybenzo[d]thiazol-2-yl)-N-(3-(tritylthio)propyl)aniline (2-25b) 
The procedure is the same as for compound 2-25a. Yield: 59%.
1
H NMR (400 MHz, 
Chloroform-d) δ: 7.85 (d, J = 8.8 Hz, 1H), 7.81 (d, J = 8.4 Hz, 2H), 7.2-7.5 (m, 16H), 
7.02 (dd, J1 = 8.8 Hz, J2 = 2.0 Hz, 1H), 6.53 (d, J = 8.4 Hz, 2H), 3.88 (s, 3H), 3.13 (m, 
2H), 2.30 (m, 2H), 1.68 (m, 2H). 
 
2-(4-(6-methoxybenzo[d]thiazol-2-yl)phenylamino)ethanethiol (2-26a) 
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Compound 2-25a (92 mg, 0.15 mmol) and triethylsilane (60 l, 0.375 mmol) were 
dissolved in 1:1 TFA/DCM mixture (4 ml). The resultion solution was stirred at r.t. for 
1.5 h, and neutralized with sat. NaHCO3 to pH ~ 6. The organic layer was separated, 
and the aqueous layer was extracted with DCM (2  15 ml). The combined organic 
layers were washed with sat. NH4Cl and dried over Na2SO4. The product was isolated 
with silica gel column (hexanes/EtOAc = 2:1). Yield: 42 mg (80%). 
1
H NMR (400 
MHz, Chloroform-d) δ: 7.86 (m, 3H), 7.32 (d, J = 2.4 Hz, 1H), 7.04 (dd, J1 = 8.8 Hz, 
J2 = 2.4 Hz, 1H), 6.68 (m, 2H), 3.88 (s, 3H), 3.43 (m, 2H), 2.81 (m, 2H).
 13
C NMR 
(100 MHz, CDCl3) δ: 167.6, 129.7, 128.5, 122.1, 112.9, 104.4, 55.8, 44.6, 33.4, 29.7, 
22.5, 14.1. HRMS (ESI+): m/z calculated for C16H17N2OS2 [M]
+
,317.07902; found 
317.07823. 
 
3-(4-(6-methoxybenzo[d]thiazol-2-yl)phenylamino)propane-1-thiol (2-26b) 
The procedure is the same as for compound 2-25a. Yield: 80%. 
1
H NMR (400 
MHz, Chloroform-d) δ: 7.87 (m, 3H), 7.32 (d, J = 2.8 Hz, 1H), 7.03 (dd, J1 = 8.8 Hz, 
J2 = 2.4 Hz, 1H), 6.67 (d, J = 8.4 Hz, 2H), 3.88 (s, 3H), 3.35 (m, 2H), 2.67 (m, 2H), 
1.96 (m, 2H).
 13
C NMR (100 MHz, CDCl3) δ: 126.4, 120.5, 113.0, 109.9, 101.8, 53.3, 
39.3, 30.7, 30.5, 29.4, 27.1, 20.1, 19.6, 11.6. HRMS (ESI+): m/z calculated for 
C17H19N2OS2 [M]
+
,331.09393; found 331.09388. 
 
2-(4-(dimethylamino)phenyl)-6-(2-hydroxyethoxy)-3-methylbenzo[d]thiazol-3-iu
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m (2-29) 
Compound 2-33 was treated as general procedure 2B (yield: 65%), and the product 
was mixed with 4:1 acetonitrile/water mixture (30 ml) and CsF (10 eqiv.). The 
resulting solution was refluxed for 2 h, and the solvents were removed under vacuum. 
The product was isolated by HPLC purification. 
1
H NMR (400 MHz, Chloroform-d) δ: 
7.91 (d, J = 8.8 Hz, 1H), 7.64 (d, J = 8.8 Hz, 2H), 7.52 (m, 1H), 7.41 (m, 1H), 6.88 (d, 
J = 8.8 Hz, 2H), 4.31 (s, 3H), 4.25 (m, 2H), 4.06 (m, 2H), 3.17 (s, 6H). 
 
2-(4-(dimethylamino)phenyl)-3-methyl-6-(2-(methylsulfonyloxy)ethoxy)benzo[d]t
hiazol-3-ium (2-30) 
Compound 2-29 (20 mg, 0.045 mmol) and DIPEA (9.3 l, 0.054 mmol) were 
dissolved in anhydrous DCM (1 ml), and added with mesyl chloride (2.6 l, 0.054 
mmol) at 0 
o
C. The resulting solution was stirred at r.t. for 1 h. DCM was then 
removed under vacuum, and the product was isolated by HPLC purification. Yield: 86 
from 2-28. 
1
H NMR (400 MHz, CD2Cl2) δ: 7.94 (d, J = 9.2 Hz, 1H), 7.75 (s, 1H), 
7.70 (d, J = 8.8 Hz, 2H), 7.44 (m, 1H), 6.88 (d, J = 9.2 Hz, 2H), 4.62 (m, 2H), 4.44 (m, 
2H), 4.30 (s, 3H), 3.16 (s, 6H), 3.10 (s, 3H).
 13
C NMR (100 MHz, CD2Cl2) δ: 158.8, 
154.8, 137.7, 132.6, 119.9, 117.8, 112.8, 111.1, 107.7, 68.4, 67.7, 40.6, 39.0, 38.2. 
HRMS (ESI+): m/z calculated for C19H23N2O4S2 [M]
+
, 407.109375; found 407.11230. 
 
N-(4-(6-methoxybenzo[d]thiazol-2-yl)phenyl)acetamide (2-31) 
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The procedure is the same as for compound 2-3. Yield: 74%. 
1
H NMR (400 MHz, 
DMSO-d6) δ: 10.25 (s, 1H), 7.97 (d, J = 8.0 Hz, 2H), 7.90 (d, J = 8.8 Hz, 1H), 7.76 (d, 
J = 8.0 Hz, 2H), 7.69 (d, J = 2.0 Hz, 1H), 7.11 (dd, J1 = 8.8 Hz, J2 = 2.0 Hz, 1H), 3.85 
(s, 3H), 2.10 (s, 3H).  
 
N-(4-(6-hydroxybenzo[d]thiazol-2-yl)phenyl)acetamide (2-32) 
The procedure is the same as for compound 2-4. Yield: 93`%. 
1
H NMR (500 MHz, 
DMSO-d6) δ: 10.23 (s, 1H), 7.95 (d, J = 9.0 Hz, 2H), 7.81 (d, J = 8.5 Hz, 1H), 7.75 (d, 
J = 9.0 Hz, 2H), 7.39 (d, J = 2.5 Hz, 1H), 6.98 (dd, J1 = 8.5 Hz, J2 = 2.5 Hz, 1H), 2.10 
(s, 3H). 
 
N-(4-(6-(prop-2-ynyloxy)benzo[d]thiazol-2-yl)phenyl)acetamide (2-33) 
Followed general procedure 2A. Yield: 73%. 
1
H NMR (500 MHz, Acetone-d6) δ: 
8.02 (d, J = 8.8 Hz, 2H), 7.94 (d, J = 9.2 Hz, 1H), 7.83 (d, J = 8.8 Hz, 2H), 7.70 (d, J 
= 2.4 Hz, 1H), 7.20 (dd, J1 = 9.2 Hz, J2 = 2.4 Hz, 1H), 4.92 (d, J = 2.0 Hz, 2H), 2.96 
(m, 1H), 2.14 (s, 3H). 
 
4-(6-(prop-2-ynyloxy)benzo[d]thiazol-2-yl)aniline (2-34) 
N-(4-(6-(prop-2-ynyloxy)benzo[d]thiazol-2-yl)phenyl)acetamide (2-33) (100 mg, 
0.32 mmol) was refluxed in 10 ml 1.2 N HCl for 16 h. After cooled to r.t., the reaction 
solution was neutralized to pH 7-8 with 1 M NaOH, and then extracted with DCM (3 
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 10 ml). The combined organic layers were washed with brine and dried over 
Na2SO4. The product was purified with silica gel column (hexane/EtOAc = 3:2). Yield: 
87 mg (95%). 
1
H NMR (500 MHz, Chloroform-d) δ: 7.88 (d, J = 9.0 Hz, 1H), 7.84 (d, 
J = 9.0 Hz, 2H), 7.43 (d, J = 2.5 Hz, 1H), 7.11 (dd, J1 = 9.0 Hz, J2 = 2.5 Hz, 1H), 6.73 
(d, J = 9.0 Hz, 1H), 4.76 (d, J = 2.5 Hz, 2H), 2.55 (m, 1H). 
 
2-(4-azidophenyl)-6-(prop-2-ynyloxy)benzo[d]thiazole (2-35) 
To a solution of 4-(6-(prop-2-ynyloxy)benzo[d]thiazol-2-yl)aniline (2-34) (18 mg, 
0.064 mmol) in 2 ml acetonitrile was added t-butyl nitrite (11.4 l, 0.096 mmol) at 0 
o
C. After stirred 10 min at 0 
o
C, the resulting solution was added with 
azidotrimethylsilane (10 l, 0.077 mmol) dropwise. The reaction was then stirred at r.t. 
for another 1.5 h. The solvent was removed under vacuum, and the product was 
isolated with silica gel column (5:1 hexane/EtOAc). Yield: 18 mg (92%). 
1
H NMR 
(500 MHz, Chloroform-d) δ: 8.03 (d, J = 8.5 Hz, 2H), 7.95 (d, J = 9.0 Hz, 1H), 7.46 
(d, J = 2.0 Hz, 1H), 7.17 (dd, J1 = 9.0 Hz, J2 = 2.0 Hz, 1H), 7.12 (d, J = 8.5 Hz, 2H), 
4.78 (d, J = 2.5 Hz, 2H), 2.57 (m, 1H). 
 
2-(4-azidophenyl)-3-methyl-6-(prop-2-ynyloxy)benzo[d]thiazol-3-ium (2-36) 
Followed general procedure 2B. Yield: 55%. 
1
H NMR (400 MHz, Acetone-d6) δ: 
8.22 (d, J = 9.2 Hz, 1H), 8.02 (d, J = 2.4 Hz, 1H), 7.90 (d, J = 9.2 Hz, 2H), 7.57 (dd, 
J1 = 9.2 Hz, J2 = 2.4 Hz, 1H), 7.05 (d, J = 9.2 Hz, 2H), 5.02 (d, J = 2.4 Hz, 2H),  
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4.47 (s, 1H). 
 
 
Spectroscopic characterization of ThT derivatives 
 
All ThT monomer derivatives were stored in DMSO stock solution at 2.5 mM 
(dimers at 1.25 mM) and diluted into a phosphate buffer (50 mM phosphates, 300 mM 
NaCl, pH 7.4) in all tests below. UV/Vis spectra were collected for each ThT 
monomer at 5 μM (dimer at 2.5 μM) in the phosphate buffer.  The extinction 
coefficient values were obtained from the absorption spectra at 410 nm. 
The fluorescence excitation spectra of ThT and diThT-PEG3 were collected in the 
phosphate buffer with 2μM Aβ-(1-40) fibril on a Fluorolog-3 fluorimeter and a 
MicroMax 384 microwell plate reader (Jobin Yvon Inc. Edison, NJ). The small 
molecule concentration used was 2 M for ThT and 1 μM for diThT PEG3. The result 
shows that the ThT monomer and dimer share the same excitation profile (max = 
440 nm). The fluorescence intensity difference is due to the fact that diThT-PEG3 
binds better than the ThT monomer under the experimental conditions.  
Since only the portions of ThT derivatives bond to amyloid show fluorescence 
emission, the measurements of quantum yields were disrupted by the binding 
constants. Therefore, the quantum yield of ThT was measured at the plateau and set as 
a relative standard. The quantum yields for all other ThT monomer and dimer 
derivatives were also taken at their plateaus and compared with ThT. The result shows 
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that all ThT derivatives have similar quantum yields as ThT, and the difference is no 
more than 2 folds. All the other details of the results are shown in the section 2.3. 
The photobleaching spectra of ThT and diThT-PEG2 were collected in the 
phosphate buffer with 2 μM Aβ-(1-40) fibril on a Fluorolog-3 fluorimeter (Jobin Yvon 
Inc. Edison, NJ). The small molecule concentration used was 1 M for ThT and 0.5 
μM for diThT PEG2. The samples were excited at 440 nm, and the emission 
fluorescence intensity was collected at 490 nm over 7,000 s (Figure 2-16). The result 
shows that photobleaching is not significant for either the monomer or the dimer. 
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Figure 2-16. The photobleaching spectra of ThT and diThT-PEG2 
 
A40 synthesis  
 
Aβ40 was synthesized through the standard Fmoc/ tBu chemistry with the 
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Fmoc-Phe-Wang resin (Novabiochem) as the solid support. The synthesis was carried 
out on 0.1 mmole scale. Five equivalents of amino acids and HBTU were used for the 
coupling reaction. To ensure the quality of the peptide, double couplings were carried 
out for residues after all beta-branched amino acids. The peptides were cleaved off the 
resin and deprotected with TFA (95% TFA, 2.5% H2O, 2.5% triethylsilane). The crude 
products were purified by RP-HPLC (Waters Prep LC, Jupiter 10u C18 300A  
 
Figure 2-17. Analytical HPLC trace of the synthetic A40 exhibiting good purity (a) and ESI-MS 
result confirming the identity of the peptide (b).  
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Column). The integrity of the peptide was conformed by LC-MS, which showed the 
purity is greater than 90% (Figure 2-17). 
 
Preparation and characterization of Aβ40 fibrils 
 
In order to prepare Aβ40 amyloid, the peptide was treated according to a published 
protocol to obtain fresh Aβ40 monomers. Briefly, the lyophilized Aβ40 peptide was 
dissolved in 1 mM NaOH solution, filtered through 0.22 μM syringe filter (Millipore, 
Billerica, MA), and then through a Centricon filter with 10KDa molecular weight 
cutoff (Millipore, Billerica, MA). The peptide was diluted into the phosphate buffer 
(50 mM phosphates, 300 mM NaCl, pH 7.4); the concentration was determined by the 
tyrosine absorption at 280 nm right after the dilution. The sample was put on the 
rotating wheel at 30 rpm. The aggregation progress was monitored by circular 
dichroism spectroscopy, which showed complete aggregation after seven days. The 
formation of beta-sheet rich amyloids was confirmed by CD data (Figure 2-18) and 
the Congo red binding assay (Figure 2-19). The stock fibril solution was stored at 2 ℃ 
and used within 2 weeks. 
Congo Red assay: 
[25]
 The Congo Red stock was prepared in 90% phosphate buffer 
saline (10 mM phosphate, 2.7 mM KCl, and 137 mM NaCl; pH 7.4) and 10% ethanol. 
The concentration was determined by measuring the absorbance of a diluted aliquot in 
a solution of sodium phosphate (1 mM, pH 7.0) and 40% ethanol at 505 nm. The 
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stock solution of Aβ40 amyloid was mixed with the Congo Red stock in phosphate 
buffer (50 mM phosphates, 300 mM NaCl, pH 7.4) to yield a final concentration of 20 
μM Congo Red and 20 μM Aβ-(1-40) fibril. Two control samples were prepared: (1) a 
solution of 20 μM Congo Red alone and (2) a solution of 20 μM Aβ40 amyloid alone. 
The UV/Vis absorption spectra of all three samples were collected and shown below. 
The spectral shift allowed us to back calculate the amyloid concentration, which 
nicely agreed with the concentration that we prepared it to be. This result indicates 
Aβ40 aggregation largely yielded beta-sheet structured amyloid, rather than 
non-specific aggregates. 
 
Figure 2-18. Circular dichroism spectrum of the aggregated A40.  
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Figure 2-19. UV/Vis absorption shift of Congo red binding to A amyloid. 
 
Measuring the amyloid binding affinities of the ThT derivatives 
 
The Aβ40 amyloid stock solution was sonicated in ice-water bath for 1 h and added 
into solutions of a ThT derivative at various concentrations. The final concentration of 
Aβ40 amyloid was set at 2 μM. The fluorescence emission was scanned immediately 
in a 384 well microplate (50 μL each sample) at 465-650 nm with the excitation at 
440 nm and slits as 6 nm on a Fluorolog-3 fluorometer and a MicroMax 384 
microwell plate reader (Jobin Yvon Inc. Edison, NJ). Triplicates of each sample were 
prepared and measured.  
The fluorescence intensity at 485nm was plotted against the small molecule 
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concentration, yielding the binding curves shown in the section 2.3. 
  
Evaluating the binding specificity of the ThT dimers to A40 amyloid 
 
The stock Aβ40 amyloid fibril solution was sonicated for 1 h and diluted to various 
concentrations into solutions of 1 μM ThT or 0.5 μM diThT derivatives and 10% (v/v) 
bovine serum (protein concentration ~60-80 mg/ml) in phosphate buffer. The 
fluorescence emission was scanned immediately in a 96 well microplate (3 × 150 μL 
each sample) at 465-650 nm with the excitation at 440 nm on a Spectra Max M5 
microwell plate reader (Molecular Devices, Sunnyvale, CA). The data are shown in 
the section 2.4. 
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1H NMR and 13C NMR Spectra 
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